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Nutrient restriction is a relatively common production insult to pregnancy in cattle.
Recently, melatonin supplementation has been investigated as a possible therapeutic to rescue
the negative effects of nutrient restriction. Neurotransmitters have been implicated as having
negative programming effects in mouse and human pregnancies, manifested as metabolic and
neurologic disorders. The role of neurotransmitters in fetal development has only begun to be
understood in mice and humans. Neurotransmitters have not been analyzed in cattle, much less
within the context of a compromised pregnancy. Brangus heifers were allotted to one of four
treatments (ADQ-CON, RES-CON, ADQ-MEL, RES-MEL) in either Fall 2019 or Summer
2020. Cesarian sections at day 240 of gestation allowed for fetal and placental tissues to be
collected for neurotransmitter and gene expression analysis. Alterations to neurotransmitter
pathways were observed in a seasonally dependent manner. Future investigation is needed into
the implications of altered neurotransmitters on post-natal life.
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CHAPTER I
REVIEW OF LITERATURE
Developmental Programming
In humans, the first connection made between offspring and gestational conditions
occurred in response to the Dutch Hunger Winter of 1944 to 1945. Pregnant women living
through this winter underwent nutrient restriction that resulted in decreased birth weights,
increased postnatal mortality, and increased incidence of type 2 diabetes in their offspring (Stein
et al., 2004; Barker, 1997). From this retrospective study and other epidemiological studies, the
“Barker hypothesis” emerged, and the concept of developmental programming was introduced.
Developmental programming is the process by which a stimulus or insult introduced during
development results in permanent alterations to the structure, physiology and metabolism of the
offspring (Godfrey, 2002). During critical periods of growth or rapid cell division, the
consequences of any stimuli or insult are elevated (Barker and Clark, 1997). Developmental
plasticity is the greatest in utero, and impacts on performance, physiology and metabolism can be
profound and persistent. Recently, long-term health impacts of in utero stressors have been
referred to as developmental origins of adult health and disease (DOHaD) and has become a
priority of human research studies. This concept of developmental programming has also
become especially relevant in livestock species since animals intended for meat production spend
a majority of their life supported by their dam in utero.
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Fetal Development
Following fertilization, growth of the conceptus is separated into two distinct phases,
embryonic growth and fetal growth. In cattle, the embryonic stage typically refers to the first 45
days of development. During this phase, three germ layers develop from the inner cell mass into
the various differentiated cells, tissues, and organs through the process of gastrulation (Gilbert,
2000). The endoderm is the inner-most layer and forms the internal glands and organs including
the reproductive system, urinary system, and parts of the digestive systems (Tam and Behringer,
1997). The mesoderm is the middle cell layer and develops into the skeletal, muscular and
cardiovascular systems, including the heart (Tam and Behringer, 1997). The ectoderm is the
outermost layer that develops into the epidermis, nervous system, and other connective tissues
(Tam and Behringer, 1997). Beyond the inner cell mass, the outer cells of the developing embryo
are called the trophectoderm and will develop into the placenta (Schlafer et al., 2000). The fetal
growth phase in cattle occurs beyond day 45 of gestation. Over the course of gestation,
exponential growth of the fetus will occur, with the most rapid period of growth in the second
and third trimesters ending in a plateau just prior to parturition (O’Rourke et al., 1991). As a
general rule, development of the vital organs will precede the development of muscle, bone, or
adipose tissues (Du et al., 2010).
Role of The Placenta
During embryonic development, the trophectoderm and mesoderm fuse to create the
chorion of the placenta (Schlafer et al., 2000). Through extensive fate-mapping of the mesoderm,
it is acknowledged that this group of cells also contributes to formation of the allantois as it
develops from the hindgut of the embryo as a fluid-filled pocket (Tam and Beddington, 1987;
Kinder et al., 1999). Together, the chorion and allantois are fused to form the chorioallantois
2

which functions as the fetal contribution to the placenta. Depending on the species, the
chorioallantois will develop into various shapes and structures giving rise to different placental
types (Schlafer et al., 2000). For example, mice and humans form a discoid placenta type while
livestock species, such as cattle and small ruminants, have a cotyledonary placental type. These
attachment types vary in structure, but the function of the placenta as the site of exchange of gas,
waste, nutrients and hormones between the dam and fetus remain similar (Hoffmann and
Schuler, 2002).
Throughout pregnancy, placental growth and development is crucial for maintenance of
pregnancy and insurance of normal fetal growth and development. The last half of pregnancy is
characterized by exponential fetal growth (Reynolds and Redmer, 1995). However, in this same
time period, placental growth is drastically slowed by comparison (Reynolds and Redmer, 1995).
To maintain the nutritional needs of the growing fetus and support homeostasis in utero, blood
flow is increasingly partitioned to the gravid uterus through increases in blood volume and
placental vascularity (Reynolds and Redmer, 1995; Redmer et al., 2004; Bollwein et al., 2002).
Through Doppler ultrasonography, Bollwein et al. (2002) found that uterine blood flow was
drastically increased to the ipsilateral uterine horn in the third trimester of gestation. In cattle,
this blood supply to the uterus and fetus is primarily supplied by the uterine artery.
For the cotyledonary placental type seen in ruminants, nutrient transfer between dam and
fetus occurs at a unique placental structure called the placentome. The placentome is composed
of a maternal caruncle found on the uterus and fetal cotyledon tissue on the placenta. With this
epitheliochorial placentation, the maternal and fetal portions are closely associated yet minimally
invasive, separate tissues (Reynolds et al., 2005). The blood flow relationship between maternal
and fetal supply in the bovine is a mixture of crosscurrent and countercurrent supply at the
3

capillary level (Leiser et al., 1997). This special blood exchange allows for efficient gas
exchange, anchoring of the placenta, and targeted hormonal control through the interdigitated
villi (Leiser et al., 1997). Angiogenesis in these tissues is increased through the duration of
pregnancy through rearrangement of the villous trees (Leiser et al., 1997). The structural changes
throughout mid- to late-gestation make the placenta a major focus of developmental
programming research as scientists examine how small physiological changes may impact blood
supply and transcriptomics of this complex organ.
The placenta is a transient organ upon which the survival of early life is dependent. Due
to the high amount of vascularity, rapid growth, and sex-hormone dependence, the placenta
remains highly susceptible to fluctuations in the environment (Furukawa et al., 2019). The
placenta plays a key role in maintaining fetal homeostasis in instances of maternal under- and
overnutrition, maternal stress, infection or disease, and presence of environmental toxins. Many
organs in the fetus are dependent upon the placenta for protection from in utero challenges and
supply of factors promoting fetal growth.
Fetal Sex
It is important to note the growing evidence supporting that the sex of the placenta may
impact the characteristics of the organ. Until recently, most biomedical studies had pooled data
from placentas of both male and female fetuses (Clifton, 2010). Given the extra-embryonic
origins of the placenta, it is logical to assume that sexual differences may continue to be present
through gestation. In humans and mice, the sex of the fetus affects the size of the placenta and its
ability to respond to adverse stimuli (Mao et al., 2010; Clifton et al., 2010). Analysis of genes
involved in amino acid metabolism and transport in the bovine placenta showed sex-differences
in transcript abundance (Sturmey et al., 2010). Under high-fat maternal diets, murine placentas
4

expressed sexually dimorphic genes with 16 genes consistently affected by both sex and nutrition
(Gabory et al., 2012). Furthermore, studies from Gregg et al. (2010a, 2010b) reported sexually
dimorphic genomic imprinting in the brain of the mouse. Tarrade et al. (2015) more recently
suggested that epigenetic mechanisms may be the causal link between sex and the observed fetal
programming effects. This growing evidence supports further investigation into sexual
dimorphism in the placenta and hints to a connection between the placenta, fetal brain, and
nutritional status as factors possibly affecting fetal programming.
Nutrient Restriction
As emphasized in humans through the retrospective study of the Dutch Hunger Winter,
the effects of maternal undernutrition can have profound impacts on the offspring’s later life.
Fetal undernutrition can result from maternal undernutrition or reduced placental efficiency
(Sultana et al., 2017; Krishna and Bhalerao, 2011). This commonly results in decreased birth
weights and intrauterine growth restriction (IUGR), also referred to as fetal growth restriction
(FGR) in humans (Nardozza et al., 2017; Long et al., 2009). The American College of Obstetrics
and Gynecology has defined FGR as fetal weight below the 10th percentile for gestational age
(ACOG, 2000). This is the most commonly used definition in medicine, and based on this
definition, it is an estimated that FGR occurs in 5-10% of all human pregnancies worldwide
(Frøen et al., 2004). Additionally, Frøen and colleagues (2004) found that 52% of intrauterine
deaths in fetuses at least 22 weeks of age in Olso, Norway from 1986 to 1995 were affected by
IUGR. Results like this highlight the high risk for mortality associated with IUGR fetuses. Fetal
growth restriction remains as a leading cause of morbidity in humans and is major contributor to
lifelong neurological disorders, cardiovascular disease, and type 2 diabetes (Barker, 1997).
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In livestock species, the model of maternal nutrient restriction has been used to further
understand the mechanisms and consequences of IUGR. Nutrient restriction in early to midgestation in sheep led to decreased numbers of myofibrils and downregulation of several
catabolic enzymes demonstrating alteration to muscle composition and potential predisposition
for obesity and diabetes (Zhu et al., 2006). In cattle, early gestational undernutrition has resulted
in decreased fetal body weight and increased brain weight as a percentage of fetal weight (Long
et al., 2009). From a mechanistic perspective, nutrient restriction causes decreased blood flow,
placental development, and vascularity in cattle (Vonnahme et al., 2007; Lemley et al., 2018). In
livestock production, most animals will undergo some form of nutrient restriction in their life.
This is mostly due to regional and seasonal variability in quantities and qualities of forage
throughout the various production stages. With the documented detriments to the fetus as a result
of nutrient restriction, great research interest has been focused on potential therapeutics that may
rescue fetal development.
Melatonin as a Therapeutic
Melatonin supplementation has emerged as a potential therapeutic for nutrient restriction
with a growing body of literature in livestock species. Melatonin was first isolated by Lerner et
al. (1958) from lyophilized beef pineal glands. Synthesized from the amino acid tryptophan,
melatonin functions as a neuroendocrine hormone secreted by the pineal gland (Tamura et al.
2008; Lemley and Vonnahme, 2017). Most commonly, it is associated with the roles it plays in
modulating circadian rhythms and seasonal breeding (Wehr, 1997; Lehman et al., 2010). In
regards to its function as a potential therapeutic, melatonin works in two ways; as an antioxidant
and acting as a modulator of vasoconstriction and vasodilation.
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During pregnancy, reactive oxidative species (ROS) can have negative effects on the
dam, placenta, and fetus as they can cause damage to cellular membranes (Reiter et al., 2009).
Oxidative stress occurs when free radicals, such as superoxide and nitric oxide, are generated to
a point beyond the body’s antioxidant production capacity (Castillo et al., 2005). Chronic forms
of oxidative stress have been linked to disorders in pregnancy, such as preeclampsia (Reiter et
al., 2009). Melatonin is able to bind directly to the cellular membrane through G-protein coupled
melatonin membrane receptors (MT1 and MT2) and reduce ROS (Paulis and Simko, 2007;
Thakor et al., 2010). Furthermore, these mechanisms work to induce vasodilation and
vasoconstriction to change flow of blood (Paulis and Simko, 2007; Lemley et al., 2013).
Melatonin has induced vasodilation of the aorta, pulmonary artery and vein, and basilar arteries
of rabbits and rats (Shibita et al., 1989; Weekley, 1991; Weekley, 1993), as well as
vasoconstriction in rat and fetal sheep cerebral arteries (Geary et al., 1997; Torres-Farfan et al.,
2008).
Melatonin is capable of crossing the placental blood barrier without alteration (TorresFarfan et al., 2008). The presence of MT1 and MT2 receptors has been documented in human
placental explants, and caruncle and cotyledon portions of sheep and cattle placentas (Lanoix et
al., 2008; Lemley et al., 2013; Lemley and Vonnahme, 2017). Previous research has shown that
melatonin supplementation increased umbilical blood flow in sheep and increased uterine artery
blood flow in cattle (Lemley et al., 2012; Brockus et al., 2016). Most recently, Contreras-Correa
et al. (2021) found that melatonin supplementation increased uterine blood flow in late gestation
of Brangus heifers. Furthermore, fetal weights were rescued by melatonin supplementation in
nutrient restricted dams in a seasonally-dependent manner (Contreras-Correa et al., 2021). In
terms of fetal programming, the effects of melatonin on blood flow provide convincing evidence
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for its use as a potential therapeutic for the nutrient restriction model, especially when
supplemented over the summer months.
The Central Nervous System
The central nervous system is prioritized in terms of development throughout gestation,
irrespective of nutrient availability to the fetus (Zhu et al., 2006; Du et al., 2010). Development
of the nervous system begins in the embryonic stage, but is not finalized until early in postnatal
life. During the embryonic stage, neurulation, the process by which neuroectodermal cells from
the neural tube develop into the brain and spinal cord, occurs (Smith and Schoenwolf, 1997). At
day 90 of gestation, there is differentiation of the primary central nervous system regions and the
main structures begin to resemble the morphology of their mature forms (Ferreira et al., 2018).
From day 110 until parturition, the telencephalon, diencephalon, mesencephalon, metencephalon,
and myelencephalon are developed in structure and function (Ferreira et al., 2018).
In instances of nutrient restriction in utero, the vital organs, including the central nervous
system, are preserved. This mechanism, known as brain-sparing, consists of the redistribution of
blood to maximize the supply of oxygen and nutrients to the brain (Scherjon et al., 1993). In
IUGR fetuses, the growth of the brain is increased, at the expense of the growth of the rest of the
body and organs, in an asymmetric growth pattern (Severi et al., 2000). Severi et al. (2000)
found, through Doppler ultrasonography of IUGR fetuses, fetal cardiac output was redistributed
to favor the left ventricle to enhance blood supply to the brain. This results in increased brain to
body weight ratios as documented in cattle experiments by Long et al. (2009). Physiologically,
there is observational evidence of IUGR offspring having short and long-term deficiencies in the
limbic system which results in impairments to cognition and emotion (Miller et al., 2016; de Bie
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et al., 2010). Though brain-sparing exists as a compensatory mechanism, the brain remains a
vulnerable organ to programming effects caused by environmental changes in utero.
Hypothalamus
The hypothalamus plays a major role in maintaining homeostasis and is associated with
energy metabolism, metabolic control, and energy expenditure. The hypothalamus is divided into
four portions: preoptic area (most rostral), anterior hypothalamus, tuberal hypothalamus, and the
posterior hypothalamus (most caudal). During the first 24 days of bovine embryonic
development, the hypothalamus is derived from the ventral portion of the diencephalon and the
preoptic area is derived from the telencephalon (Ferreira et al., 2018). In the mature brain, the
hypothalamus is positioned ventral to the thalamus and third ventricle while being immediately
dorsal to the pituitary gland. Within the hypothalamus, many neuroendocrine cell types are
concentrated into a relatively small brain volume (Romanov et al., 2020). Furthermore, regions
of specialized cells, called nuclei, support and control distinct physiological roles (Michaud,
2001). Of note, the anterior hypothalamus includes the suprachiasmatic nucleus (SCN) and
paraventricular nucleus (PVN) which help regulate feeding and circadian rhythms (Xie and
Dorsky, 2017). The tuberal hypothalamus includes divisions of the arcuate nucleus (ARC) and
median eminence (ME) which play roles in energy balance, stress responses, and aggression (Xie
and Dorsky, 2017).
The hypothalamus functions as the connection between sensory inputs from the body and
the body’s endocrine response to those stimuli. Stimuli travel from the periphery to the brain
where information is integrated. Hormones are released into circulation in response to external
stimuli and bind to receptors in the brain and other tissues (Simerly, 2005). In terms of appetite
regulation, the hypothalamus senses changes in circulating nutrients and hormones from
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peripheral tissues, such as adipocytes, the pancreas, the gastrointestinal tract, and other brain
regions (McMillen and Robinson, 2005). Hypothalamic regulation is based on the ability to
detect when the body is in need of nutrients. It is capable of regulating feed intake through
sensations and body weight through changes to metabolism. Hunger and satiety stimulate the
ARC through neurons that traverse the blood-brain barrier (BBB) and come in direct contact
with the blood stream (Jolly-Amado et al., 2014). This allows for energy-related peptides, such
as leptin, insulin, and ghrelin in the blood, to be sensed and the appropriate physiological
response to be initiated.
The hypothalamus is most commonly associated with its role in the various
hypothalamic-pituitary axes in the body. Early experiments by Harris and Green (1940-1955)
found connections between the hypothalamus and pituitary gland (Raisman, 1997). Today this
anatomical relationship represents a key point of integration between the autonomic nervous
system and endocrine systems. The unique blood circulation of the hypothalamus and pituitary
gland are essential to their function as endocrine organs (Michaud, 2001). The multiple
hypothalamic-pituitary axes in the body, such as the hypothalamic-pituitary-adrenal axis or
hypothalamic-pituitary-gonadal axis, are controlled by negative and positive feedback loops of
hormones designed to maintain body homeostasis.
Neurotransmitters
The major classes of neurotransmitters include amino acids, peptides, monoamines, and
purines though this list is not all-inclusive as it is likely that more than 100 substances can have
functions as neurotransmitters. The neurotransmitters, epinephrine, norepinephrine, dopamine,
histamine and serotonin, are classified as biogenic amines as they are biogenic substances
containing one or more amine groups (Cooper, 2001; Gainetdinov et al., 2018). Generally, their
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functions include regulating cognitive abilities, mood, and behaviors (Carrasco and Van de Kar,
2003).
Cognitive and emotional deficiencies in the limbic system have been hypothesized to be
related to the changes in neurotransmitter profiles (Palmitter, 2007; Berumen et al., 2012; Miller
et al., 2016). Serotonin specifically has become a hot topic in developmental programming of the
brain as there is accumulating evidence supporting serotonin as a contributor to mental illness in
humans (Hendricks et al., 2003; Yang et al., 2014). Dopamine metabolism and signaling has also
been implicated in mental illness within disorders like schizophrenia and attention deficit
hyperactivity disorder (ADHD) (Heinz and Schlagenhauf, 2010; Tripp and Wickens, 2012). Both
catecholamines and serotonin, and their implications in fetal programming will be discussed
more thoroughly.
Catecholamine Synthesis and Metabolism
The main catecholamines are epinephrine, norepinephrine, and dopamine. In 1939,
Blaschko postulated the classical pathway for dopamine biosynthesis. At the time, dopamine was
only assumed to serve as the precursor to epinephrine and norepinephrine (Blaschko, 1942).
Catecholamine synthesis begins in catecholaminergic neurons with the hydroxylation of tyrosine
by tyrosine hydroxylase (TH) to yield L-dihydroxyphenylalanine (L-DOPA). Aromatic amino
acid decarboxylase (AADC; also DOPA decarboxylase, coded for by DDC gene) converts LDOPA to dopamine. Tyrosine hydroxylase is the rate-limiting step of catecholamine synthesis
(Dunkley et al., 2004). Interestingly, TH is only coded by one gene, TH, with regulation on
transcriptional and post-transcriptional levels (Kobayashi and Kaneda, 1988; Kumer and Vrana,
1996, Sabban et al., 2006). Though AADC is not the rate limiting step in dopamine synthesis, it
has been noted that its activity is dependent on dopamine levels and the relationship is one of
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negative feedback (Cumming et al., 1997; Gjedde et al., 1993). It is important to also note that
nearly half of the dopamine in the body is synthesized in the gastrointestinal tract (Eisenhofer et
al., 1997). Still dopaminergic neurons can be found clustered in the arcuate nucleus of the
hypothalamus with axon projections into the median eminence (Kawano and Daikoku, 1987).
There are 5 types of dopamine receptors in the body, D1, D2, D3, D4, and D5, with D1 (DRD1)
and D2 (DRD2) being the most abundant in the central nervous system (Jaber et al., 1996).
From dopamine, epinephrine can be synthesized. Dopamine beta-hydroxylase (DBH)
adds a hydroxyl group to dopamine to yield norepinephrine. In cells synthesizing epinephrine,
phenylethanolamine N-methyltransferase (PNMT) catalyzes the conversion from norepinephrine
to epinephrine. Norepinephrine and epinephrine signals are received by alpha and beta
adrenergic receptors found on various tissues and have been associated with “fight or flight”
physiological responses of the sympathetic nervous system (Molinoff, 1984).
After the neurotransmitter is released into the synaptic cleft, it interacts with the postsynaptic receptors. It is possible for nondegraded catecholamines to be reused by the body
through repackaging of the neurotransmitters in vesicles of the neurons, but at some point the
catecholamines will be metabolized (Axelrod, 1971). Two primary pathways for dopamine
metabolism exist, but both yield homovanillic acid (HVA) as the final product (Meiser et al.,
2013). Both pathways utilize the enzymatic actions of monoamine oxidase (MAO), catechol-O
methyl transferase (COMT) and aldehyde dehydrogenase (ALDH). In the first pathway, COMT
metabolizes dopamine to 3-methoxytyramine (3-MT) which undergoes further degradation by
MAO and ALDH to produce HVA. The other pathway first utilizes MAO to make 3,4dihydroxyphenylacetaldehyde (DOPAL) which is further oxidized by ALDH to yield 3,4dihydroxyphenylacetic acid (DOPAC). 3,4-dihydroxyphenylacetic acid can further undergo 3-O
12

methylation by COMT to yield HVA. For humans and mice, DOPAC and HVA are the primary
metabolites and main excretion products of dopamine (Uutela et al., 2009; Swahn and Wiesel,
1976). Furthermore, norepinephrine and epinephrine are also metabolized by COMT and MAO.
However, their primary metabolite is vanillylmandelic acid (VMA). Catecholamines and their Omethylated metabolites are expelled from the body in urine. Catecholamine synthesis,
metabolism and signaling are outlined in Fig. 1.1.
Catecholamine Implications
Generally speaking, dopamine is associated with the human feelings of pleasure and
reward. However, the physiological implications of dopamine metabolism and synthesis go
beyond the “good” feelings. Dysregulation of dopamine has been implicated in disorders like
schizophrenia and attention deficit hyperactivity disorder (ADHD) (Heinz and Schlagenhauf,
2010; Tripp and Wickens, 2012). Specifically, the metabolism of all catecholamines by MAO
generates hydrogen peroxide as a byproduct which can lead to oxidative stress in
catecholaminergic neurons. Oxidative stress has been associated with a variety of neuronal
disorders including Alzheimer’s disease, Parkinson’s disease, and schizophrenia (Metodiewa and
Koska, 2000). Major alterations to catecholamine concentrations can change metabolism and
production of ROS which can have lasting effects in the brain.
Mouse knockout models for COMT and MAO have yielded interesting associations with
behavior. A knockout mouse model elucidated that COMT is most abundant in microglial cells
in the central nervous system, but was not detected in dopaminergic neurons (Myohanen et al.,
2010). Additionally, COMT knockout mice have been observed to have increased aggressive
behavior indicating that decreased COMT enzymatic activity results in an aggressive phenotype
(Gogos et al., 1998). Furthermore, COMT knockout mice exhibited sexually dimorphic
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behaviors and catecholamine levels. Notably, male mice had increased dopamine compared to
females, while female mice exhibited increased anxious behavior compared to their male
counterparts (Gogos et al., 1998).
Two genes encoding the MAO enzyme are located on the X chromosome. Each gene
coding for a different form of MAO, MAO-A and MAO-B. In humans, dopamine is mostly
oxidized by MAO-B, but in rats, MAO-A is more common (Bach et al.,1988; Napolitano et al.,
1995). In humans and mice, MAOA has been identified as being involved in pathological
aggression (Sabol et al., 1998; Craig and Halton, 2009). However, in both MAOA and MAOB
knockout mice, no changes in dopamine levels were observed (Cases et al., 1995; Grimsby et al.,
1997). Interestingly, genotyping in the Lidia cattle breed, selected for aggressive behavior,
revealed a significant polymorphism in the promoter region of the MAOA gene indicating a
possible influence of the gene on cattle behavior (Eusebi et al., 2020).
Caution is to be given to extrapolation from animal to human models as there are species
differences in dopamine metabolism and synthesis (Meiser et al., 2013). However, the
implications of behavioral changes in animals provide intriguing evidence to support research
expansion into more animal models. Aggression appears to be the most notable difference in
animal behavior across the literature, but anxiety in response to stress and novel experiences, as
seen in the female COMT knockout mice, might also be expected (Gogos et al., 1998). There is a
general lack of knowledge on the specificities of dopamine synthesis, metabolism, and
implications in cattle warranting extensive additional research on the topic.
Catecholamines in the Placenta
There is some evidence supporting the placenta as a dopaminergic/adrenergic organ.
Dopamine is found in human amniotic fluid and dopamine receptors, D1 and D2, have been
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found on rat and human placental explants (Ben-Jonathan and Munsick, 1980; Villancourt et al.,
1994; Kim et al., 1997; Kim et al., 2001). Zhu et al. (2002) used immunohistochemistry to locate
norepinephrine and dopamine in human placenta. Mao et al. (2020) localized dopamine to
trophoblast giant cells in the mouse placenta. Additionally, dopamine concentrations were
increased in response to exposure to bisphenol A and bisphenol S, as endocrine-disrupting
chemicals (Mao et al., 2020). In human placenta, norepinephrine transport (NET) and
extraneuronal monoamine transporter (MET), on trophoblast cells, transport and internalize
catecholamines (Bottalico et al., 2004). Bottalico et al. (2004) associated reduced mRNA for
NET and MET with preeclampsia pregnancies with the hypothesis that the receptors may help
ensure blood flow to the fetus by preventing catecholamine induced vasoconstriction.
Serotonin Synthesis and Metabolism
Rapport et al. (1948) were the first to name serotonin after isolating it from bovine serum.
However, Italian pharmacologist, Vittorio Erspamer, had actually discovered the amine in rabbit
gastric mucosa in 1937, calling the substance “enteramine” (Erspamer and Vialli, 1937).
Notably, an estimated 95% of peripheral serotonin is found in enterochromaffin cells in the
gastrointestinal tract and in blood platelets (Liu et al., 2021). The pathway for serotonin synthesis
begins with the conversion of tryptophan to 5-hydroxytryptophan (5-HTP) by tryptophan
hydroxylase (TPH). Tryptophan hydroxylase is the rate-limiting stepfor serotonin synthesis and
exists in two forms, TPH1 and TPH2, encoded by two independent genes (Walther and Bader,
2003). The enzyme, TPH1, is primarily found in enterochromaffin cells, while TPH2 is mainly
expressed in the central nervous system and serotonergic neurons (McKinney et al., 2005; Patel
et al., 2004). 5-hydroxytryptophan is decarboxylated by the enzyme aromatic amino acid
decarboxylase (AAAD) to produce serotonin. Serotonin is taken into epithelial cells by
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serotonin-selective reuptake transporters (SERT) controlled by the SLC6A4 gene (Wade et al.,
1996; Lesch et al., 1996). Serotonin receptors are further classified into 14 receptor subtypes.
Additionally, it should be noted that serotonin is a precursor to synthesis of melatonin. The
enzymes, aralkylamine N-acetyltransferase (AANAT) and acetylserotonin O-methyltransferase
(ASMT), are responsible for the synthesis of melatonin from serotonin and are expressed only at
high levels in the pineal gland (Rath et al., 2016). Serotonin is metabolized by MAO to yield 5hydroxyindoleacetic acid (5-HIAA) which is excreted from the body in urine. Serotonin
synthesis, metabolism and signaling are outlined in Fig. 1.2.
Serotonin in the Placenta
Until recently, it was thought that serotonin was transferred from the dam to the fetus
through blood circulation until fetal brain serotonin synthesis was initiated (Cote et al., 2007).
Sources of serotonin outside of the fetal brain must exist since serotonin receptors are observed
in areas prior to the growth of axons connecting to those regions (Buznikov et al., 2001).
Generally, there is conflict among the literature regarding the source of serotonin in utero.
However, Bonnin and Levitt (2011) proposed a new model of placental contribution to fetal
brain and blood serotonin that has since become a viable theory. Bonnin et al. (2011) uncovered
a placental serotonin synthesis pathway from maternal tryptophan in mice and humans using an
ex vivo technology regulating live placental organ profusion in the mouse. Still, Kliman et al.
(2018) found results in direct conflict with this theory with evidence of serotonin being conveyed
through maternal blood circulation, yet their study was based fully on in vitro placental explants.
Bonnin and Levitt’s theory has been further supported by results supporting the ability of the
placenta to synthesize serotonin (Tuteja et al., 2016; Laurent et al., 2017; Mao et al., 2020).
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However, this debate is likely not over as new research and reviews in the field continue to shape
current knowledge about the source of fetal serotonin.
Serotonin Implications
It is important to note that in the adult brain, peripherally synthesized serotonin cannot
cross the BBB and must be synthesized by the brain itself, but tryptophan can cross the BBB
freely (Patrick and Ames, 2014). However, the immature BBB does allow exogenous serotonin
to pass into the brain. Alterations to placental serotonin production have been hypothesized to
increase risk for autism spectrum disorders and FGR (Yang et al., 2014; Ranzil et al., 2019a;
Ranzil et al., 2019b). Early studies of ASD found hyperserotonemia, drastically increased
serotonin concentrations, in 30% of autistic individuals (Schain and Freedman, 1961). More
specifically, abnormal platelet serotonin has been observed in ASD children and their close
relatives (Abramson et al., 1989). Serotonin stimulates cell division, neuronal migration, and
synaptogenesis during fetal brain development (Yang et al., 2014). It is hypothesized that excess
serotonin in utero may cause a negative feedback loop inhibiting serotonin signaling long-term
for immature brains (Rosenfeld, 2021). Boylan et al. (2007) found that serotonin deficiency in
neonatal mice lead to abnormally large brain growth and similar behavioral characteristics to
ASD. Placental hyperserotonemia and hyposerotonemia, decreased serotonin levels, are likely
causes for disrupted neural programming in the fetus.
It is not possible to fully discuss the implications of serotonin in utero without presenting
some of the results surrounding the use of serotonin reuptake inhibitors (SSRI). Major depressive
disorder (MDD) is a devastating mood disorder that has been predicted to be the second leading
cause of incapacity worldwide by 2030 according to the World Health Organization (WHO,
2008). Additionally, MDD has been associated with HTR1A gene expression in Asian
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populations (Kishi et al., 2009). As an antidepressant, SSRIs are the most common
pharmacological intervention for MDD (Oberlander et al., 2006). They work by inhibiting the
presynaptic reuptake of serotonin at the SERT which increases serotonin at the postsynaptic
membrane (Santarsieri and Schwartz, 2015). Serotonin reuptake inhibitors are being prescribed
to pregnant women at an increasing rate (Huybrechts et al., 2013). However, prescribed use of
SSRIs has been associated with increased prevalence and risk of preterm delivery, intrauterine
growth restriction, and neurobehavioral disturbances (Oberlander et al., 2009). It is hypothesized
that these effects are likely caused by the drugs transferring across the placenta and increasing
serotonin concentrations in the fetal brain (Hendrick, 2003). The implications of SSRIs on fetal
brain development continue to be a hot topic of biomedical and pharmaceutical research.
Gene regulation of the serotonergic pathway has contributed to further understanding of
the implications of serotonin. The YWHA-genes code for the regulatory 14-3-3 proteins of
TPH1/2 as well as tyrosine hydroxylase (Banik et al., 1997; Kleppe et al., 2014). Polymorphisms
in YWHA-genes has been implicated in ADHD and related neuropsychiatric conditions
(Jacobsen et al., 2015). Monoamine oxidase A knockout mice had increased serotonin and
decreased 5-HIAA at birth and increased aggressive behavior as adults (Cases et al., 1995).
Klasen et al. (2019) have further supported the association with low MAO allele frequency and
aggression in humans with their recent study.
The relationship between serotonin and nutrition has not been fully elucidated.
Eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), and vitamin D have been proposed
to modulate serotonin synthesis, release and function (Patrick and Ames, 2015). Patrick and
Ames (2015) found that sufficient EPA levels were important for regulation of serotonin release
and DHA mediated regulated function of SERT. Vitamin D has been further implicated in the
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regulation of TPH transcription (Haussler et al., 2011). In an induced IUGR guinea pig model,
concentrations of serotonin and 5-HIAA were increased in the brain (Jensen et al., 1996). Salas
et al. (2007) found that pregnant rats treated with 5-HTP had decreased fetal body weights. More
recently, Ranzil et al. (2019a) found associations with FGR and altered mRNA expression of
components of the serotonin synthesis pathway in the placenta from humans. Though there are
implications of decreased nutrition leading to FGR and FGR to disruptions in the serotonin
pathway, the direct impact of a dietary restriction on serotonin has yet to be discussed in the
literature.
Placenta-Brain-Axis
Recently, in a review by Rosenfeld (2021), the term placental-brain-axis was used to
describe the interconnectedness of the placenta and brain as they relate to long-term
programming effects occurring in utero. It is well-known that the placenta produces steroid
hormones (Reimers et al., 1985; Roberts et al., 1995), but placental production of
neurotransmitters is less-recognized and a relatively new field of reproductive study. Currently,
few research articles report results including full neurotransmitter profiles outside of the
traditional mouse and human models demonstrating a lack of knowledge, specifically in
livestock species. Specifically, no studies on neurotransmitter profiles have been conducted in
cattle. Furthermore, few studies have looked at the implications of common production scenarios
such as IUGR and nutrient restriction as they relate to fetal brain development. Recently, studies
of IUGR in litter-bearing species such as rabbits and pigs have shown changes in
neurotransmitter profiles in response to nutrient restriction with some conflicting results in HVA
and DOPAC concentrations (Garcia-Contreras et al., 2017; Vasquez-Gomez et al., 2016;
Hernandez-Andrade et al., 2015). In general, this field of study has been minimally researched
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and deserves extensive further investigation. Understanding the way placental changes may alter
fetal brain development may lead to better understanding of neurobehavioral disorders in humans
and mechanisms of programming in livestock species.
Statement of the Problem
The beef cattle industry accounted for $72.2 billion in cash receipts in 2021 (USDA,
2022). The cow-calf sector produces the animals destined for the meat supply and the next
generation of heifers as breeding stock. At some point in their life, most beef cattle will undergo
at least some form of nutrient restriction due to regional and seasonal variability in quantities and
qualities of forage throughout the various production stages. Due to the concept of
developmental programming, the time spent in utero represents a critical period for both meat
and breeding animals that can drastically change phenotypes. Nutrient restriction has detrimental
effects to the fetus’s growth and future performance. Recently, melatonin has emerged as a
therapeutic to recover some of the detriments from nutrient restriction through its properties as
an antioxidant and ability to improve blood flow to the uterus.
In humans, the effects of fetal growth restriction have been linked to neurological deficits
and developmental origins of adult health and disease (DOHaD). Neurotransmitters have
emerged as the proposed cause of these disorders by way of transmission to the fetus in utero via
the placenta. Excess serotonin has been implicated in autism spectrum disorders and fetal growth
restriction while dopamine signaling is related to schizophrenia and Parkinson’s disease.
Additionally, genes involved in neurotransmitter synthesis and metabolism have been associated
with aggression and anxiety. Generally, the implications of neurotransmitters can only be
speculated in cattle. The neurological deficits discussed in humans and mice do not have direct
analogues to cattle behavior. However, it is possible that the behavioral disruptions could be a
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consequence of alterations to neurotransmitter concentrations or their respective pathways. For
cattle, these likely could be manifested in cattle as aggression, nervous responses to stressors, or
changes in feeding behaviors.
Literature reporting neurotransmitter profiles in response to nutrient restriction in utero is
minimal. Even more limited is the knowledge of placental production of neurotransmitters as a
programming mechanism in cattle. From this literature review many questions arise about the
possible programming effects of the placenta on the fetal brain and the role neurotransmitters
may play in this mechanism. This project aimed to (i) determine the effects of maternal nutrient
restriction, melatonin supplementation, and time of sampling on the presence of
neurotransmitters and relative gene expression in the fetal hypothalamus, blood and cotyledon,
and (ii) gather novel evidence of a placental-brain axis as a possible mechanism of fetal
programming in cattle.

21

Figure 1.1

Catecholamine synthesis, metabolism, and signaling pathway

The catecholamine synthesis, metabolism and signaling is detailed. Dopamine is synthesized
from tyrosine by the enzymes, tyrosine hydroxylase (TH) and dihydroxyphenylalanine
decarboxylase (DDC), in the yellow boxes. Dopamine is signaled to tissues through dopamine
receptor D1 (DRD1) and dopamine receptor D2 (DRD2), in the grey boxes. Dopamine can be
metabolized to 3,4-dihydroxy-phenyl acetic acid (DOPAC) and homovanillic acid (HVA) by the
enzymes, monoamine oxidase A (MAOA) and catechol-O-methyltransferase (COMT), in the
orange boxes. Dopamine can be further synthesized into epinephrine and norepinephrine by the
enzymes, dopamine beta-hydroxylase (DBH) and phenylethanolamine N-methyltransferase
(PNMT), respectively, in the green boxes.
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Figure 1.2

Serotonin synthesis, metabolism, and signaling pathway

Serotonin synthesis, metabolism and signaling is detailed. Serotonin is synthesized from
tryptophan by the enzymes, tryptophan hydroxylase (TPH) and aromatic amino acid
decarboxylase (AAAD), in the yellow boxes. Serotonin is signaled to tissues through serotonin
receptor, 5-hydroxytryptamine receptor 1A (HTR1A), and serotonin reuptake transporter, solute
carrier family 6 member 4 (SLC6A4), represented by the grey boxes. Serotonin can be
metabolized to 5-hydroxyindolacetic acid (5-HIAA) by the enzyme, monoamine oxidase A
(MAOA) in the orange box. Serotonin can be further synthesized into melatonin by the enzymes,
aralkylamine N-acetyltransferase (AANAT) and acetylserotonin O-methyltransferase (ASMT),
in the green boxes.
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CHAPTER II
MATERNAL NUTRIENT RESTRICTION
Abstract
The placenta modulates fetal brain development in mice and humans, with a paucity of
information reported in cattle. The objective was to determine the effects of maternal nutrient
restriction, melatonin supplementation, and time on neurotransmitter concentrations in the
cotyledon, fetal hypothalamus, and fetal blood. At day 160 of gestation, 29 spring-calving and 25
fall-calving Brangus heifers were assigned to one of four treatments: adequately fed (ADQCON; 100% NRC recommendation), nutrient restricted (RES-CON; 60% NRC
recommendation), and ADQ or RES supplemented with 20 mg/d of melatonin (ADQ-MEL;
RES-MEL). Fetuses were removed at day 240 of gestation, at either 0500h or 1300h, for
collection of placentomes, blood, and hypothalamic tissue. Neurotransmitters (serotonin, 5-HT;
dopamine, DA; norepinephrine, NE; epinephrine, EPI) and metabolites (3,4dihydroxyphenylacetic acid, DOPAC; 5-hydroxyindoleacetic acid, 5-HIAA; homovanillic acid
HVA) were analyzed by LCMS or HPLC in blood or tissues, respectively. Transcript abundance
of genes in the serotonin pathway (HTR1A, SLC6A4, YWHAB, MAOA) and catecholamine
pathway (TH, DDC, COMT, DRD1, DRD2) were determined by RT-PCR. Data were analyzed
by ANOVA using the mixed procedure of SAS with seasons analyzed separately. In springcalving heifers, melatonin increased (P  0.05) concentrations of DOPAC, DA, 5-HIAA, and
HVA in the cotyledon. Additionally, increased (P = 0.02) mRNA transcript abundance of
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MAOA in the cotyledon indicates increased overall neurotransmitter metabolism. Nutrient
restriction and melatonin supplementation increased (P  0.05) blood 5-HT. In both calving
seasons, there was a nutrition by treatment interaction in hypothalamic 5-HT (P  0.01), whereby
RES-MEL was increased compared with ADQ-MEL. For fall-calving heifers, no differences
were observed in neurotransmitter concentrations in the cotyledon. Hypothalamic NE was
increased (P = 0.02) in RES vs. ADQ, while hypothalamic and blood DA were decreased (P 
0.05) in RES vs. ADQ. Hypothalamic 5-HIAA was increased (P = 0.05) in the MEL vs. CON,
while blood EPI was decreased (P = 0.04) in MEL vs. CON. Concentration of DA and transcript
abundance of DDC had a nutrition by treatment effect (P  0.05), whereby RES-MEL was
decreased. The concentration of 5-HT was increased (P = 0.02) in the morning compared with
the afternoon in blood plasma. In summary, nutrient restriction, melatonin supplementation, and
time alter concentrations of neurotransmitters and their metabolites in a seasonally dependent
manner.
Key words: hypothalamus, neurotransmitters, placenta
Lay summary
The time spent in utero has been identified as a critical period of development where the
effects of insults are heightened and may cause permanent alterations. Nutrient restriction is a
common condition of gestating cattle due to seasonal changes in forage quantity and quality.
Melatonin increases blood flow and rescues the negative effects of nutrient restriction.
Neurotransmitters, such as serotonin or dopamine, in the placenta have recently been implicated
in numerous mental disorders. Our results show, in cattle, nutrient restriction and melatonin
supplementation can change the concentrations of neurotransmitters and their metabolism in the
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placental and fetal tissues. It is possible that fluctuations in neurotransmitters could alter
behavior and lead to aggression in later life.
Introduction
Neurotransmitters are signaling molecules created by neurons that diffuse across a
synapse to transfer impulses. Neurotransmitters, such as epinephrine, norepinephrine, serotonin
and dopamine, have multiple functions in the body, but generally are responsible for regulating
cognitive abilities, mood, and behavior (Carrasco and Van de Kar, 2003). However, cognitive
and emotional deficiencies in the limbic system have been hypothesized to be related to the
changes in neurotransmitter profiles (Palmitter, 2007; Berumen et al., 2012; Miller et al., 2016).
Dopamine metabolism and signaling has also been implicated in mental illness within disorders
like schizophrenia and attention deficit hyperactivity disorder (ADHD) (Heinz and
Schlagenhauf, 2010; Tripp and Wickens, 2012). Serotonin specifically has become a hot topic in
developmental programming of the brain as there is accumulating evidence supporting serotonin
as a contributor to mental illness, with specific association with autism spectrum disorders (Yang
et al., 2014). Additionally, polymorphisms in the MAOA gene and knockout mouse models have
revealed a connection between the gene coding for the enzyme metabolizing neurotransmitters
and aggression in mice, humans, and cattle (Cases et al., 1995; Klasen et al., 2019; Eusebi et al,
2020).
During critical periods of growth or rapid cell division, the consequences of any stimuli
or insult are elevated (Barker and Clark, 1997). Changes in the maternal environment such as
stress and nutritional status, can have life-long impacts on fetal physiology and performances.
Due to the high amount of vascularity, rapid growth, and sex-hormone dependence, the placenta
remains highly susceptible to fluctuations in the environment (Furukawa et al., 2019). Though
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there continues to be debate among the literature, the placenta has been implicated as a
transporter of neurotransmitters to the developing fetus. Bonnin et al. (2011) uncovered a
placental serotonin synthesis pathway from maternal tryptophan in mouse placenta. Presence of
dopamine, norepinepherine, catecholamine transporters, and dopamine receptors have been
found on the placenta suggesting it as a dopaminergic/adrenergic organ (Kim et al., 1997; Zhu et
al., 2002; Bottalico et al., 2004; Mao et al., 2020). Recently, the term placental-brain-axis has
been used to describe this interconnectedness of the placenta and brain as they relate to longterm programming effects occurring in utero (Rosenfeld, 2021).
At some point in their life, most beef cattle will undergo at least some form of nutrient
restriction due to regional and seasonal variability in quantities and qualities of forage
throughout the various production stages. Maternal nutrient restriction can result in decreased
fetal weights and increased risk for metabolic disease in later life in animal and human models
(Long et al., 2009; Zhu et al., 2006; Stein et al., 2004). Melatonin supplementation has emerged
as a potential therapeutic for nutrient restriction due to its ability to cross the placenta and enter
fetal circulation and its properties as an antioxidant and modulator of blood flow (Tamura et al.,
2008; Paulis and Simko, 2007; Lemley et al., 2013). Melatonin has been shown to increase
umbilical and uterine artery blood flow in sheep and cattle, respectively (Lemley et al., 2012;
Brockus et al., 2016). Most recently, Contreras-Correa et al. (2021) found that melatonin
supplementation increased uterine blood flow in late gestation of Brangus heifers. Furthermore,
this study found fetal weights were rescued by melatonin supplementation in nutrient restricted
dams in a seasonally dependent manner (Contreras-Correa et al., 2021). Still, the impacts of
melatonin and nutrient restriction on the expression of genes modulating neurotransmitter
synthesis and metabolism and concentrations of neurotransmitters has not been studied in cattle.
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We hypothesized that maternal nutrient restriction and dietary melatonin during the last
half of pregnancy would alter neurotransmitter pathways in the hypothalamus, fetal blood and
placenta. We also hypothesized that samples collected 4-hours before and after feeding would
show temporal changes in neurotransmitter pathways. Our objectives were to determine the
effects of nutrient restriction, melatonin supplementation, and time of sampling on the presence
of neurotransmitters and relative gene expression in the hypothalamus, blood and placenta.
Furthermore, we aimed to gather novel evidence of a placental-brain axis as a possible
mechanism of fetal programming in cattle.
Materials and Methods
Animal management and treatments
Animal care and use were according to protocols approved by the Mississippi State
University Institutional Animal Care and Use Committee (protocol #17-709). Methods for heifer
management and treatment were previously described (Contreras-Correa et al., 2021). Briefly,
180 commercial Brangus heifers (2019, n = 80; 2020, n = 100) underwent a fixed-time 7-day
CO-Synch + CIDR protocol with artificial insemination 55 h after prostaglandin injection using
semen from one commercially available Angus sire. Animals were intentionally randomly
assigned to one of eight breeding groups and service dates over a 3-week period in either year.
Pregnancy was confirmed via trans-rectal ultrasonography at day 35 post-insemination. Twentynine pregnant heifers were enrolled in the study for Fall 2019 with expected calving dates in
January. Twenty-five pregnant heifers were enrolled in the study for Summer 2020 with
expected calving dates in October.
At day 140 of gestation, heifers underwent a 20-day acclimation period to allow for
adjustment to use the Calan Broadbent Feeding System (American Calan, Northwood, NH,
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USA). At day 160 of gestation, heifers were stratified by body weight and assigned to one of
four dietary treatments in a 2 X 2 factorial design; adequately fed (ADQ-CON; 100% NRC
recommendation), nutrient restricted (RES-CON, 60% NRC recommendation), and adequately
fed or nutrient restricted supplemented with 20 mg/d of melatonin (ADQ-MEL; RES-MEL). For
Fall 2019, animal number and distribution per treatment was ADQ-CON (n = 7), RES-CON (n =
7), ADQ-MEL (n = 7), and RES-MEL (n = 8). For Summer 2020, animal number and
distribution per treatment was ADQ-CON (n = 6), RES-CON (n = 6), ADQ-MEL (n = 6), and
RES-MEL (n = 7).
Heifers were provided a TMR consisting of a base diet (71.65% DM) and grass hay
(20.7% DM) with an ad libitum water source. Additionally, independent of treatment, all heifers
received 0.90 kg/day of a grain mix (7.65 % DM, and 22.64 % protein, 8.40 % ADF, 7.42 % fat)
used to top dress the treatments. Further dietary composition is described previously (ContrerasCorrea et al., 2021). Melatonin (#14427; Cayman Chemical Company, Ann Arbor, MI) was
dissolved in absolute ethanol at a concentration of 10 mg/mL. Melatonin-treated animals
received the grain ration with 2 mL of melatonin solution top-dressed, whereas the control
groups received 2 mL of absolute ethanol. Methods for melatonin dietary supplementation have
been described previously (Brockus et al., 2016). Feeding occurred at 0900 h with heifers first
receiving their grain mix (MEL vs. CON treatment) and, once consumed, receiving their TMR
(ADQ vs. RES treatment) through the Calan gates electronic feeding system. Diets were adjusted
weekly based on maternal body weight.
Cesarean section procedures
At day 240 of gestation, heifers underwent Cesarean sections for fetal tissue collection
according to Lemley et al. (2018). Surgeries were performed at the H. H. Leveck Animal
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Research Center. Briefly, surgical procedures were performed on the dam while standing in the
squeeze chute. Following a paravertebral or inverted-L block with 2% lidocaine, the skin
surrounding the incision site was prepared for aseptic surgery. A 20 cm incision was made
ventral to the transverse processes of the paralumbar fossa. The frontal limbs of the fetus were
identified and used as a handle to deliver the gravid uterus to the incision site. After a uterine
incision was made, the umbilical cord was located, clamped, and cut. Surgeries took
approximately 25 minutes and were performed at either 0500 or 1300 hours. For Fall 2019,
animal number and distribution per treatment was AM (n = 15) and PM (n = 14). For Summer
2020, animal number and distribution per treatment was AM (n = 12) and PM (n = 13). Cattle
were monitored for clinical signs of infection by a veterinarian daily for four weeks postoperation.
Fetal tissue collection
After fetal removal, a placentome was excised from the uterine wall nearest to the
umbilical cord. Caruncle (maternal) and cotyledon (fetal) portions of the placentome were
separated. The cotyledon tissue was placed in cryogenic tubes, snap frozen in liquid nitrogen and
stored at -80C until further analysis. Fetal body weights were taken and fetal blood was
collected during exsanguination. Fetal blood was collected in K2 ethylenediamine tetraacetic acid
(EDTA) blood tubes (BD Vacutainer, Franklin Lakes, NJ, USA) and immediately placed on ice.
Samples were centrifuged at 2,000 g for 12 minutes, and plasma aliquots were collected and
stored at -80C. After exsanguination, fetal necropsies were performed. To remove the brain, the
scalp was excised and the skull cap removed with an oscillating saw. Once the brain was
evacuated and weighed, an incision was made through the optic chiasm to expose the
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hypothalamus immediately dorsal to the infundibulum and mamillary body. A 1 cm x 1 cm
sample of the hypothalamus was placed in cryogenic tubes, snap frozen in liquid nitrogen and
stored at -80C until further analysis.
Neurotransmitter analysis
Samples of hypothalamus, cotyledonary tissue and blood plasma were shipped to
Vanderbilt University Neurochemistry Core supported by the Vanderbilt Brain Institute and the
Vanderbilt Kennedy Center for analysis of biogenic amines. Aliquots of 250 L of fetal blood
plasma were analyzed using LCMS. Approximately 25 mg of cotyledonary and hypothalamic
tissue were analyzed via HPLC-electrochemical detection. Results from HPLC-ECD were
normalized to tissue weight.
For LCMS analysis, stock solutions of biogenic amines (5ng/L each) were made in DI
water and stored at -80C. To prepare internal standards, stock solutions were derivatized in a
similar manner to samples using isotopically labeled benzoyl chloride. 50L of the amino acid
stock solution was diluted with 200L acetonitrile. 100L each of 500mM NaCO3 (aq) and 2%
13

C6-BZC in acetonitrile was added to the solution. After two minutes, the reaction was stopped

by the addition of 200L 20% acetonitrile in water containing 3% sulfuric acid and 400L water.
This solution was stored in 10L aliquot at -80C. One aliquot was diluted 100x with 20%
acetonitrile in water containing 3% sulfuric acid to make the working internal standard solution
used in the sample analysis.
Analytes in plasma were quantified using liquid chromatography/mass spectrometry
(LC/MS) methodology following derivatization with benzoyl chloride (BZC) (Wong et al.,
2016). 20L of plasma was diluted with 60L acetonitrile:water (80:20) and vortexed. The
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solution was centrifuged at 3.5g for 5 minutes to pellet proteins. 5L of supernatant was added
10L each of 500mM NaCO3 (aq) and 2% BZC in acetonitrile. After two minutes, the reaction
was stopped by the addition of 10L internal standard solution.
LC was performed on a 2.0 x 50 mm, 1.7m particle Acquity BEH C18 column (Waters
Corporation, Milford, MA, USA) using a Waters Acquity UPLC. Mobile phase A was 15%
aqueous formic acid and mobile phase B was acetonitrile. Samples were separated by a gradient
of 98–5% of mobile phase A over 11 minutes at a flow rate of 600L/min prior to delivery to a
SCIEX 6500+ QTrap mass spectrometer. Biogenic amines detected were norepinephrine (NE),
epinephrine (EPI), dopamine (DA), 3,4-dihydroxy-phenyl acetic acid (DOPAC), 3methoxytyramine (3-MT), homovanillic acid (HVA), serotonin (5-HT), and 5hydroxyindolacetic acid (5-HIAA), and are expressed in concentrations of ng/mL.
For HPLC-ECD analysis, tissues were kept frozen at -80C and were held on dry ice
prior to the addition of homogenization buffer in order to prevent degradation of biogenic
amines. Tissues were homogenized, using a handheld sonic tissue dismembrator, in 100-750 L
of 0.1M TCA containing 0.01M sodium acetate, 0.1mM EDTA, and 10.5 % methanol (pH
3.8). 10L of homogenate was used for the protein assay. The samples were then centrifuged in a
microcentrifuge at 10,000 g for 20 minutes. Supernatant was removed for HPLC-ECD analysis.
HPLC was performed using a Kinetix 2.6m C18 column (4.6 x 100 mm, Phenomenex,
Torrance, CA USA). The same buffer used for tissue homogenization is used as the HPLC
mobile phase. Protein concentration in cell pellets is determined by BCA Protein Assay Kit
(Thermo Scientific). 10L tissue homogenate is distributed into 96-well plate and 200 L of
mixed BCA reagent (25 mL of Protein Reagent A is mixed with 500 L of Protein Reagent B) is
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added. The plate was incubated at room temperature for two hours for the color development. A
BSA standard curve is run at the same time. Absorbance is measured by the plate reader
(POLARstar Omega), purchased from BMG LABTECH Company. Biogenic amines detected
were norepinephrine (NE), dopamine (DA), 3,4-dihydroxy-phenyl acetic acid (DOPAC), 3methoxytyramine (3-MT), homovanillic acid (HVA), serotonin (5-HT), and 5hydroxyindolacetic acid (5-HIAA), and are expressed in concentrations of ng/mg of tissue.
Real-time PCR
RNA was extracted from frozen cotyledonary and hypothalamic tissue. Approximately
25mg of tissue was homogenized in 0.35 mL of RLT Lysis buffer (QIAGEN, Hilden, Germany).
RNA were purified using the RNeasy Mini Kit following the manufacturer’s instructions
(QIAGEN, Hilden, Germany). Total extracted RNA was quantified using a NanoDrop One
spectrophotometer (Thermo Scientific, Waltham, MA) and stored at -80C. RNA samples were
diluted to a consisted concentration of 100 ng/uL. The cDNA was reverse transcribed using the
High-Capacity cDNA Reverse Transcription Kit (Thermo Fischer Scientific, Vilnius, Lithuania).
Aliquots of the cDNA was diluted 1:10 in RNase-free water and stored at -20C. RT-PCR was
performed using TaqMan probe-based assays (Applied Biosystems, Pleasanton, CA) and a
QuantStudio 3 system (Applied Biosystems, Foster City, CA). The thermocycling protocols
consisted of a hold stage at 50°C for 2 min, polymerase activation hold at 95°C for 20 s, and
95°C for 1 s followed by 60°C for 30 s for 40 cycles. Target genes included: genes associated
with serotonin synthesis, metabolism, and signaling such as 5-hydroxytryptamine receptor 1A
(HTR1A), solute carrier family 6 member 4 (SLC6A4), monoamine oxidase A (MAOA), and
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta (YWHAB); and
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genes associated with catecholamine synthesis, metabolism, and signaling such as tyrosine
hydroxylase (TH), dihydroxyphenylalanine decarboxylase (DDC), catechol-O-methyltransferase
(COMT), dopamine receptor D1 (DRD1), and dopamine receptor D2 (DRD2). Glyceraldehyde3-phosphate dehydrogenase (GADPH), ribosomal protein L19 (RPL19), and splicing factor 3a
subunit 1 (SF3A1) were measured as housekeeping genes. The significant pathways, Taqman
assay ID, RefSeq number, and the function of the genes of interest are presented in Table 2.1.
Assays were validated previously by our lab (Contreras-Correa et al., 2020; Lemley et al. 2018).
Replicate CT values were averaged and used for relative abundance quantification using the
2−ΔΔCt method. Data are reported relative to the geometric mean of GAPDH, RPL19, and SF3A1.
Statistical analysis
Data set normality was tested using the Shapiro-Wilks statistics of the UNIVARIATE
procedure of SAS version 9.4 (SAS Institute Inc., Cary, NC, USA). Non-normally distributed
variables were analyzed using a Wilcoxon Signed-Rank test. The statistical model included fixed
effects of treatment, nutritional plane, time of day, and their corresponding two-way interactions.
Random effect of artificial insemination group nested within cow was included unless G matrix
was defined as not positive definite. Fetal sex, day of gestation, maternal initial body weights
were included as covariates and were removed from the model if P > 0.20. Significant main
effects of fetal sex are reported. The best fit of the covariance structure was compound symmetry
which provided the smallest Akaike Information Criterion. Significant differences were found
for all variables between years (P  0.05). Therefore, neurotransmitter and gene expression data
were individually analyzed for 2019 and 2020 replicates of the project and will hereupon be
discussed separately as Experiment 1 (2019; fall study) and Experiment 2 (2020; summer study).
Means were separated using the PDIFF option of the LSMEANS statement. Spearman
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correlation coefficients were determined using the CORR procedure of SAS (SAS Institute Inc.,
Cary, NC, USA). Data are presented as means  standard error. Statistical significance was
declared at P  0.05.
Results
Experiment 1 – Fall Study
Neurotransmitter analysis
Neurotransmitter concentrations in the cotyledon, hypothalamus and plasma are
presented in Table 2.2. 3-MT was not detected in any of the tissues. In the cotyledon, melatonin
supplementation increased the concentrations of 5-HIAA (P = 0.0165) by 1.5-fold, DA (P =
0.0089) by 2-fold, DOPAC (P = 0.0056) by 7-fold, and HVA (P = 0.0217) by 2-fold compared
with the control. There were no differences observed for 5-HT or NE in the cotyledon (P  0.50).
No differences were observed for 5-HIAA, DA, DOPAC, HVA, or NE in the
hypothalamus (P  0.20). A nutrition x treatment interaction (P = 0.0084) was observed for 5HT, where the RES-MEL group was increased compared with the RES-CON and ADQ-MEL
groups (Fig 2.1A).
In fetal plasma, nutrient restriction increased concentrations (P = 0.0290) of 5-HT by
12.5-fold compared with the adequately fed group. Furthermore, melatonin supplementation
increased (P = 0.0438) concentrations of 5-HT by 2-fold compared with the control. A main
effect of sex was also observed for 5-HT where female fetuses (725.02  353.51, n = 12) had
increased (P = 0.0215) concentrations compared with males (485.10  246.63, n = 17) in the
hypothalamus. No differences were observed for 5-HIAA, DA, HVA, or NE (P  0.22) in
plasma. In the morning, concentrations of EPI were increased (P = 0.0293) by 2-fold compared
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with the afternoon. A nutrition x treatment interaction (P = 0.0281) for DOPAC was observed
where DOPAC concentrations were similar between ADQ-CON, RES-CON, and RES-MEL
treatments, while the ADQ-MEL group had decreased DOPAC levels compared with the ADQCON and RES-MEL groups (Fig 2.1B).
Relative mRNA expression
Transcript abundance in the cotyledon and hypothalamus are presented in Table 2.3. For
the cotyledon, TH was not detected and no differences were found in expression levels of
COMT, DDC, DRD1, YWHAB, or SLC6A4 (P  0.08). However, a main effect of sex was
observed for HTR1A where female fetuses (0.47  0.24, n = 12) had decreased (P = 0.0377)
transcript abundance compared with male fetuses (0.78  0.20, n = 17). Melatonin
supplementation increased (P = 0.0093) DRD2 expression by 5-fold compared with the control.
Also, MAOA expression was increased (P = 0.0206) by 1.25-fold in melatonin supplemented
animals compared with control animals.
In the hypothalamus, there were no differences found in transcript abundance of COMT,
TH, DRD1, DRD2, YWHAB, and MAOA (P  0.07). DDC expression was increased (P =
0.0480) by 1.5-fold in the nutrient restricted animals compared with those adequately fed.
Similarly, HTR1A was also increased (P = 0.0389) by 3.5-fold in the nutrient restricted group
compared with the adequately fed group. A time x nutrition interaction (P = 0.0433) was
observed for SLC6A4, where the PM-RES group was increased compared with the AM-ADQ
and PM-ADQ groups and AM-RES group was increased compared with PM-ADQ, but not
different from the AM-ADQ and PM-RES groups (Fig 2.2).
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Experiment 2 – Summer Study
Neurotransmitter analysis
Neurotransmitter concentrations in the cotyledon, hypothalamus and plasma are
presented in Table 2.4. 3-MT was not detected in any of the tissues. In the cotyledon, there were
no differences observed for 5-HT, 5-HIAA, DA, DOPAC, HVA or NE (P  0.09).
No differences were observed for DOPAC or HVA in the hypothalamus (P  0.09). A
nutrition x treatment interaction (P = 0.0328) was observed for 5-HT, where the RES-MEL
group was increased compared with the ADQ-MEL group and the ADQ-CON and RES-CON
levels were intermediary (Fig 2.3A). Furthermore, concentrations of 5-HT had a time x nutrition
interaction (P = 0.0092) where concentrations were similar between AM-ADQ, AM-RES, and
PM-RES treatments, while the PM-ADQ group had decreased 5-HT compared with the AMADQ and PM-RES groups (Fig 2.3B). 5-HIAA concentration was increased (P = 0.0533) by
1.25-fold in the melatonin supplemented group compared with the control. A nutrition x
treatment interaction (P = 0.0410) for DA was observed where RES-MEL and RES-CON were
increased compared with ADQ-MEL and where the ADQ-CON group was intermediary (Fig
2.3C). Additionally, DA had a time x treatment interaction (P = 0.0147) where PM-CON
concentrations were increased compared with AM-CON and PM-MEL groups (Fig 2.3D).
Concentrations of NE were increased (P = 0.0192) by 1.75-fold in the nutrient restricted animals
compared with those adequately fed.
In plasma, no differences were observed for DOPAC, HVA, or NE (P  0.11). The
concentrations of 5-HT were increased (P = 0.0216) by 7-fold in the morning compared with the
afternoon. A time x treatment interaction (P = 0.0182) was observed for 5-HIAA, where the PMMEL group was increased compared with the AM-MEL group while the AM-CON and PM50

CON levels were intermediary (Fig 2.4). DA was decreased (P = 0.0035) by 2.5-fold in the
nutrient restricted animals compared with those adequately fed. Moreover, melatonin
supplementation decreased (P = 0.0395) concentrations of EPI by 2-fold compared with the
control.
Relative mRNA expression
Transcript abundance in the cotyledon and hypothalamus are presented in Table 2.5. For
the cotyledon, TH was not detected and no differences were found in expression levels of DDC,
YWHAB, MAOA, HTR1A, and SLC6A4 (P  0.10). Nutrient restriction decreased (P = 0.0269)
COMT by 1.5-fold relative to the adequately fed group. Expression of DRD1 was decreased (P =
0.0383) by 3-fold in the nutrient restricted group compared with those adequately fed, and was
also increased (P = 0.0186) by 2-fold in animals supplemented with melatonin compared with
the control. Additionally, DRD2 expression was decreased (P = 0.0235) by 1.75-fold in the
nutrient restricted group compared with those adequately fed.
In the hypothalamus, there were no differences found in transcript abundance of COMT,
DRD2, YWHAB, and SLC6A4 (P  0.07). However, a main effect of sex was observed for
HTR1A where female fetuses (0.51  0.15, n = 13) had increased (P = 0.0457) transcript
abundance compared with male fetuses (0.25  0.05, n = 12). TH expression was increased (P =
0.0228) by 2-fold in the melatonin supplemented group compared with the control. In the
morning, DDC was decreased (P = 0.0061) by 1.25-fold compared with the afternoon. Also, a
nutrition x treatment interaction (P = 0.0048) was observed for DDC where ADQ-CON, RESMEL, and RES-CON were increased compared with the ADQ-MEL group (Fig 2.5A). DRD1
had time x nutrition interaction (P = 0.0071) where AM-ADQ and PM-RES transcript abundance
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was increased compared with AM-RES (Fig 2.5B). Also, transcript abundance of DRD1 also
was increased (P = 0.0077) in female fetuses (0.48  0.14, n = 13) compared with male fetuses
(0.27  0.05, n = 12). MAOA was decreased (P = 0.0100) by 1.75-fold in the morning compared
with the afternoon.
Spearman correlations
Correlations between the neurotransmitters in the various tissues across both studies are
presented in Table 2.6. Analysis revealed a positive correlation between 5-HT in the plasma and
concentrations of 5-HT and 5-HIAA in the cotyledon. 5-HIAA in the plasma was also positively
correlated with 5-HT and 5-HIAA in the cotyledon, as well as 5-HIAA in the hypothalamus.
Notably, HVA was positively correlated across all three tissues, with the strongest correlation
between HVA in the hypothalamus and cotyledon. DOPAC in the plasma was correlated
positively with NE in the cotyledon, while DOPAC in the cotyledon was similarly correlated
with NE in the plasma, albeit both slight correlations. EPI in the plasma was most strongly
correlated with HVA in the cotyledon, but also had a positive correlation with DA and DOPAC.
In the serotonin pathway, 5-HIAA in the hypothalamus was positively correlated with 5-HT and
5-HIAA in the cotyledon. A slight negative correlation was observed between concentrations of
NE in the hypothalamus and HVA in the cotyledon.
Correlations between the neurotransmitters and gene expression in the hypothalamus
across both studies are presented in Table 2.7. Within the serotonin pathway, a positive
correlation between the concentration of 5-HIAA and the transcript abundance of YWHAB,
MAOA, and HTR1A was observed. HVA, a metabolite of dopamine was positively correlated
with the transcript abundance of DRD1 and DRD2. Correlations between the neurotransmitters
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and gene expression in the cotyledon across both studies are presented in Table 2.8. Analysis
revealed a positive correlation between 5-HIAA and the abundance of YWHAB and SLC6A4
within the serotonin pathway. A negative correlation was observed between the transcript
abundance of DDC and the concentration of HVA. Additionally, no correlations were found
between neurotransmitter concentrations in the cotyledon, hypothalamus, and blood plasma, and
fetal body weights previously reported by Contreras-Correa et al. (2021) as shown in Table 2.9.
Discussion
As noted in our lab previously, the effect of season on melatonin supplementation and
nutrient restriction drastically changes blood flow and efficacy of melatonin as a therapeutic
supplement (Contreras-Correa et al., 2021). This is likely due to melatonin’s role as a circadian
rhythm modulator (Arendt, 1998). Similarly, the results from the current study show significant
variations between the two seasons. The main takeaways from our results is presented in Fig 2.6
In the blood plasma of the fall study, nutrient restriction increased serotonin levels by
12.5-fold. Melatonin supplementation also increased serotonin levels in the blood 2-fold. Given
the negative implications of hyperserotonemia, this may indicate a negative consequence of
melatonin supplementation on fetal brain development. Increased serotonin has been linked in
humans to ASD and FGR (Yang et al., 2014; Ranzil et al., 2019a; Ranzil et al., 2019b). Though
FGR and IUGR in livestock are similar phenomenon, ASD does not have a documented
analogue in cattle behavior. This raises questions about what the negative effects of
hyperserotonemia may manifest as in cattle, as this has yet to be looked at in the species. With
the previous results of Contreras-Correa et al (2021) showing FGR in the fall without a
melatonin rescue effect, it is notable that the effect of nutrient restriction is greatly increasing
serotonin in the blood of the fetus. Additionally, since melatonin is synthesized from serotonin, it
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is possible that exogenous melatonin supplementation decreases the use of serotonin for its
synthesis in the blood (Rath et al., 2016). However, this hypothesis is based solely on
neurotransmitter profiles. Conversely, it is possible that increases in serotonin are in response to
increases in blood volume as platelets contain a large amount of the serotonin in the body (Liu et
al., 2021). However, in the summer replicate, these results were not repeated.
Epinephrine in the blood demonstrated a circadian pattern with circulating concentrations
2-fold higher at the morning (0500 h) sampling than in the afternoon (1300 h) in the fall study
only as shown in Fig 2.6. This is different from what has been previously reported. Catheterized
Nguni cattle showed no circadian patterns of any catecholamines (Ganhao et al., 1985). More
recently, epinephrine concentrations in milk from adult Holstein cattle did show circadian
patterns (Teng et al., 2021). Teng at al. (2021) observed increased epinephrine at 1500 h
compared to 0500 h, opposite of our results. It is important to note, that our study was only
looking at the fetal tissues which could conceivably indicate a lag time due to signals crossing
the placenta from the dam. Ultimately, there is some evidence within our results demonstrating a
relationship between epinephrine and circadian rhythms, but not enough information was
gathered to speculate about the mechanisms involved. This possible circadian pattern of
epinephrine in cattle managed on strict time schedules warrants further investigation.
In the blood of the fall replicate, there was a confusing interaction where melatonin
supplementation in adequately fed animals decreased DOPAC concentration compared with
adequately-fed non-melatonin supplemented animals. However, melatonin supplementation in
restricted animals increased DOPAC concentration to the level of controls. One possible
explanation is that additional dopamine synthesis is occurring and metabolism is occurring at a
similar rate ultimately not changing the dopamine concentration in the blood. Though HVA, the
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other dopamine metabolite, is not increased, this theory is not necessarily ruled out because, in
mice and humans, both DOPAC and HVA are expelled from the body through urine (Uutela et
al., 2009; Swahn and Wiesel, 1976). Though the dopamine metabolism in the fall study does not
appear to change in either the placenta or hypothalamus, dopamine metabolism in another tissue
could change the DOPAC in circulation in this nutrition by treatment interactive effect.
Cotyledon samples from the fall study only demonstrated treatment effects with
melatonin supplementation increasing both neurotransmitters and transcript abundance. In
conflict with our results, melatonin has been shown to decrease catecholamine synthesis in
adrenal medulla explants of fetal sheep in vitro (Komatsubara et al., 2017). Komatsubara et al.
(2017) found decreased dopamine concentrations and DDC and TH expression. Our results
found increases in dopamine by 2-fold, DOPAC by 7-fold, and HVA by 2-fold in response to
melatonin supplementation as well as increased DRD2, by 5-fold, and MAOA, by 1.25-fold.
However, TH was not detected. The MAO enzyme degrades serotonin to yield 5-HIAA and
degrades dopamine to yield DOPAC. The metabolism of both serotonin and dopamine are
increased by melatonin supplementation in the cotyledon in the fall study. This is evidenced by
the increase of MAOA transcript abundance and increased concentration of the metabolites 5HIAA, DOPAC, and HVA. Additionally, MAOA has been implicated in aggression in humans,
mice, and cattle previously (Klasen et al., 2019; Cases et al., 1995; Eusebi et al., 2020).
Interestingly, genotyping in the Lidia cattle breed, selected for aggressive behavior, revealed a
significant polymorphism in the promoter region of the MAOA gene indicating a possible
influence of the gene on cattle behavior (Eusebi et al, 2020). In our study, the increased
transcript abundance of MAOA raises questions about what the implications of this increase may
be on cattle behavior in later-life.
55

Furthermore, the results from the fall study indicate additional disruptions to serotonin
signaling with increased gene expression by 3.5-fold for the serotonin receptor HTR1A in the
hypothalamus. Also, SLC6A4 was significantly higher in the PM-RES group compared to the
adequately fed animals regardless of time. Again, the implications of hyperserotonemia in cattle
are unknown. However, these results indicate a relationship between nutritional status and
serotonin. Tryptophan and vitamin B rich foods have been shown to reduce depression in mild
cases (Shabbir et al., 2013). In humans, increased serotonin is reported in response to FGR
(Ranzil et al., 2019a). Unique to the cattle model is the ability to provide a controlled nutrient
restriction. In litter bearing species, IUGR phenotypes occur spontaneously due to embryo
distribution around the uterus. For human studies, the control of diet as a percentage of nutrient
requirement is nearly impossible. Due to these characteristics, our results provide evidence that
nutrient restriction may be causative in altering serotonin concentrations and signaling in the
brain.
Contreras-Correa et al. (2021) found that during the summer study, melatonin
supplementation rescued FGR, with no difference in fetal body weights between RES-MEL and
ADQ-CON groups. In our study, plasma dopamine was decreased by 2.5-fold in the nutrient
restricted animals, as shown in Fig 2.6. Recently, dopamine signaling has been found to be
altered in IUGR mice, leading to increased impulsivity (Alves et al., 2019). Although, our study
rescued effects of IUGR, dopamine and in utero nutrition have been associated with alterations
to feeding behaviors. Van der Laan et al. (2016) hypothesized that nutrient restricted children
were more tempted by immediately rewarding foods due to alterations in dopamine
concentration and signaling. Future studies would be needed to determine if increased dopamine
in utero leads to alterations in feeding behavior in cattle.
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Additionally, in the hypothalamus, the summer replicate showed alterations to
catecholamine synthesis and metabolism. In the summer, the photoperiod is lengthened and
interestingly, the catecholamine pathway also demonstrated some circadian rhythmicity.
Dopamine concentration was influenced by both time and melatonin treatment. Within the nonmelatonin supplemented group, dopamine concentration was increased in the afternoon
compared to the morning, but dopamine levels in the AM-CON group were not different from
the AM-MEL or PM-MEL groups. TH was increased in the morning while DDC was decreased.
Dopamine in the retina has been shown to demonstrate circadian patterns, with studies in mice
demonstrating melatonin as a causative link to dopamine rhythmicity (Doyle et al., 2002). DDC,
the enzyme responsible for synthesis of dopamine, and dopamine concentrations demonstrated a
nearly identical nutrition by treatment effect where levels within the ADQ-MEL group were
decreased compared to the RES-CON and RES-MEL groups. In the fall, only an increase in
DDC transcript abundance was observed in the hypothalamus in regard to the catecholamine
pathway. Additionally, DRD1 expression was decreased in the AM-RES group compared to the
AM-ADQ and PM-RES groups. Dopamine’s relationship with the feeling of reward associated
with food intake has been discussed thoroughly within the context of human obesity (Volkow et
al., 2011). With repeat exposure to a food reward, the dopamine response habituates and is
ultimately transferred onto the stimuli associated with food (Epstein et al., 2009). In humans,
nutrient restriction in utero is correlated with increased risk of type 2 diabetes (Barker et al.,
1997). With our results, this may indicate a deeper relationship between a feeling of reward and
nutritional status as a programming mechanism in the fetus. The implications of alterations to
dopamine synthesis and signaling in post-natal life are still unanswered in cattle.
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Plasma epinephrine was also decreased 2-fold in melatonin supplemented animals, as
seen in Fig 2.6. Interestingly, in avian species, exogenous melatonin led to decreased epinephrine
concentrations in the adrenal glands (Mahata and De, 1991). Additionally, in broilers,
epinephrine increased melatonin synthesis through increased transcription of AANAT (Wang et
al., 2019). Granted, these results are not in mammals. However, in humans, MT1 receptors have
been found co-localized with corticotropin‐releasing hormone (CRH) neurons indicating a
possible relationship where melatonin modulates the hypothalamic-pituitary-adrenal axis and
subsequently epinephrine (Wu et al., 2006). Further investigation of this mechanism in cattle is
necessary to fully understand the relationship between melatonin and epinephrine.
In the summer study, the cotyledon had no differences in neurotransmitter concentrations,
suggesting a profound impact of season. However, there were differences in the relative gene
expression of COMT, DRD1, and DRD2 in the cotyledon. Dopamine receptors, DRD1 and
DRD2, were increased by 2-fold in the summer, and by 5-fold in the fall, respectively, in
response to melatonin supplementation. In the summer, DRD1 and DRD2 were decreased by 3fold and 1.75-fold, respectively, in the nutrient restricted compared with the adequately fed
animals (Fig 2.6). Activation of dopamine receptors has been implicated in mice as the
mechanism behind melatonin’s antidepressant-like effects (Binfare et al., 2010). Associations
have been found between the DRD2 gene and sleep duration in humans (Cade et al., 2016).
Given melatonin’s role in regulation of circadian rhythm, this may be an explanation for the
increased dopamine receptor transcript abundance. Interestingly, COMT knockout mice have
been observed to have increased aggressive behavior indicating that decreased COMT enzymatic
activity results in an aggressive phenotype (Gogos et al., 1998). Gogos et al. (1998) also noted in
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females that the COMT knockout did not have a significant effect on the concentrations of
dopamine. However, our results did not show that sex effect within dopamine concentrations.
In both seasons the lack of TH expression in the cotyledon of the bovine presents an
interesting result, as TH is the rate-limiting step of catecholamine synthesis (Dunkley et al.,
2004). TH has been detected in the placenta of humans (Manyonda et al., 1998). Zhu et al.
(2002) used immunohistochemistry to locate norepinephrine and dopamine in human placenta
and discovered that over the course of gestation the localization shifts from cytotrophoblasts to
synctiotrophoblast cells. TH expression has also been detected in the sheep adrenal glands with
significant decreases in TH expression in late gestation (Adams et al., 1998). It is possible that at
day 240 (late gestation) in cattle, the placenta is no longer synthesizing catecholamines and their
production has become the responsibility of the fetus itself. Nonetheless, the lack of TH
expression is intriguing.
In the summer study, the serotonin pathway exhibited variation in response to time.
Serotonin in the blood was 7-fold higher in the morning than the afternoon. Also, 5-HIAA
showed a time by treatment interaction where within the melatonin supplemented group,
afternoon sampling had higher levels of 5-HIAA in the blood plasma than in the morning. It is
plausible that the link between serotonin and photic information is also impacting the serotonin
pathway in the fetal blood.
In the hypothalamus in the summer, 5-HIAA was increased in the melatonin group.
However, the enzymes involved in serotonin metabolism showed no differences with melatonin
supplementation to support increased serotonin metabolism as an explanation. Interestingly, the
summer replicate also demonstrated some circadian rhythmicity in a time by nutrition
interaction, where adequately fed animals had higher serotonin in the morning compared with the
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afternoon, but no differences between the AM-ADQ, AM-RES, and PM-RES were observed.
MAOA gene expression also demonstrated an effect of time with decreased expression by 1.75fold in the morning compared with the afternoon, suggesting decreased neurotransmitter
metabolism. Serotonergic terminals have been discovered in the superchiasmatic nucleus (SCN)
which controls circadian rhythms (Ueda et al., 1983). Though the SCN was not analyzed in this
study, it is believed that serotonin intermediates the photic information entering the SCN since
light-induced phase shifts can be attenuated or even blocked by the injection of 5-HT agonists
(Rea et al., 1995; Weber et al., 1998).
Spearman correlations helped reveal some interesting associations when reviewed as a
whole. First, there were more correlations between neurotransmitters and their metabolites
between the blood and the cotyledon than between the blood and the hypothalamus. The blood
brain barrier is not functional until later in gestation (Daneman et al., 2010). Though the
gestational day in cattle of closure of the BBB is not fully elucidated, this late in gestation the
lack of correlation between the hypothalamus and blood may signify that this protective
mechanism is in place. Additionally, the metabolites that serve as the final product of
metabolism for serotonin, 5-HIAA, and dopamine, HVA, were correlated across all three tissues.
5-HIAA and HVA are the final products expelled from the body. Plausibly, metabolism of
serotonin and dopamine in the brain and other tissues releases the metabolites into the blood for
expulsion from the body. In the fetus, this expulsion of waste is a function of the placenta that
may explain the link between the blood and hypothalamus. However, the mechanism of this
waste expulsion is not elucidated by this study.
In conclusion, our results describe novel evidence of the presence of neurotransmitters
and their synthesis and metabolism in the fetal bovine. Similar to previous work from our lab
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(Contreras-Correa et al., 2021), neurotransmitters are greatly influenced by season likely due to
their respective abilities to influence circadian information in the brain. In the fall, melatonin
supplementation increased serotonin and dopamine metabolism in the placenta. In the summer,
the hypothalamus and blood plasma showed numerous temporal variations in neurotransmitters
and their pathways possibly because of the association with photoperiod. Still, this research only
represents a single time-point within fetal development, warranting extensive additional research
into neurotransmitters over the course of gestation and the implications of these alterations in
neurotransmitters as they relate to feeding and social behaviors in post-natal life.
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Tables and Figures
Table 2.1

Significant pathway, Taqman assay ID, RefSeq accession number, and function of
the genes of interest in the cotyledon and hypothalamus tissues

Significance

Catecholamine
synthesis,
metabolism and
signaling

Gene

Assay ID

COMT

Bt03274724_m1

TH

Bt03211746_m1

NM_173884.2

Rate-limiting enzyme for
catecholamine synthesis

DDC

Bt03211853_m1

NM_173907.2

Enzyme in catecholamine
synthesis

DRD1

Bt03223051_s1

NM_174042.2

Dopamine receptor D1

DRD2

Bt03212565_m1

NM_174043.2

Dopamine receptor D2

MAOA

Bt03251810_m1

NM_181014.2

Enzyme metabolizing serotonin
and dopamine

Bt03251740_m1

NM_174794.2

Activation of TH and TPH
enzymes

Bt07106503_s1

NP_000515.2

Serotonin receptor

SLC6A4

Bt03215364_m1

NM_174609.2

Serotonin reuptake transporter

GAPDH

Bt03210913_g1

NM_001034034.2

Glyceraldehyde-3-phosphate
dehydrogenase

RPL19

Bt03229687_g1

NM_001040516.2

Ribosomal protein L19

SF3A1

Bt03254301_m1

NM_001081510.1

Splicing factor 3a

Serotonin
synthesis,
YWHAB
metabolism and
signaling
HTR1A

Housekeeping
genes

Accession

Function

NM_001102317.1 Enzyme metabolizing dopamine

COMT, catechol-O-methyltransferase; TH, tyrosine hydroxylase; DDC, dihydroxyphenylalanine
decarboxylase; DRD1, dopamine receptor D1; DRD2, dopamine receptor D2; MAOA, monoamine
oxidase A; YWHAB, tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta;
HTR1A, 5-hydroxytryptamine receptor 1A; SLC6A4, solute carrier family 6 member 4; GAPDH,
glyceraldehyde-3-phosphate dehydrogenase; RPL19, ribosomal protein L19; SF3A1, splicing factor 3a
subunit 1
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Table 2.2

Neurotransmitter concentrations in the Fall Study
Nutrition
ADQ

Treatment
RES

CON

Time
MEL

AM

P-value
PM

Nutrition Treatment

Time

Cotyledon
5-HT

18.96 ± 2.29

21.01 ± 3.01

20.11 ± 3.26

19.94 ± 2.14

19.85 ± 2.36

20.20 ± 3.08

0.7417

0.5077

0.9193

5-HIAA

5.65 ± 0.62

6.98 ± 0.92

5.19 ± 0.75

7.41 ± 0.76

6.93 ± 0.88

5.70 ± 0.69

0.4614

0.0165

0.2365

DA

4.39 ± 0.87

4.08 ± 0.99

2.75 ± 0.37

5.61 ± 1.11

4.91 ± 1.17

3.51 ± 0.46

0.4730

0.0089

0.6918

DOPAC

0.81 ± 0.31

2.06 ± 1.47

0.35 ± 0.14

2.49 ± 1.46

2.15 ± 1.48

0.71 ± 0.24

0.3473

0.0056

0.5286

HVA

2.14 ± 0.48

2.11 ± 0.46

1.34 ± 0.18

2.86 ± 0.55

2.49 ± 0.57

1.74 ± 0.27

0.8047

0.0217

0.2599

NE

0.68 ± 0.15

1.01 ± 0.28

0.71 ± 0.14

0.99 ± 0.29

0.73 ± 0.15

0.98 ± 0.30

0.5146

0.8244

0.7270

11.24 ± 0.87

12.38 ± 0.63

–

–

0.2226

Hypothalamus
5-HT

–

–

–

–

5-HIAA

9.11 ± 0.47

10.34 ± 0.79

10.09 ± 0.95

9.43 ± 0.28

9.83 ± 0.65

9.66 ± 0.71

0.3019

0.7117

0.8400

DA

3.56 ± 0.77

2.95 ± 0.53

3.69 ± 0.90

2.83 ± 0.29

2.99 ± 0.55

3.52 ± 0.76

0.6389

0.9877

0.5116

DOPAC

1.23 ± 0.18

1.39 ± 0.24

1.39 ± 0.30

1.25 ± 0.10

1.28 ± 0.25

1.35 ± 0.16

0.4011

0.3512

0.6067

HVA

15.57 ± 2.77

13.39 ± 1.44

16.46 ± 3.04

12.56 ± 0.59

13.11 ± 1.48

15.86 ± 2.73

0.5385

0.9857

0.2311

NE

36.41 ± 4.50

31.25 ± 4.76

33.70 ± 4.89

33.78 ± 4.52

29.07 ± 4.31

38.75 ± 4.72

0.3849

0.8370

0.2009

84.94 ± 13.02

1050.52 ± 355.70

412.93 ± 228.73

744.39 ± 331.19

620.39 ± 273.22

545.80 ± 311.29

0.0290

0.0438

0.3430

859.29 ± 45.81

869.74 ± 87.11

859.89 ± 83.36

869.18 ± 58.19

871.99 ± 74.03

856.88 ± 67.28

0.9466

0.8445

0.5964

0.61 ± 0.07

0.94 ± 0.19

0.64 ± 0.09

0.91 ± 0.18

0.80 ± 0.15

0.76 ± 0.15

0.4824

0.4194

0.8843

5.11 ± 0.52

6.25 ± 0.77

–

–

0.0787

Plasma
5-HT1
5-HIAA
DA
DOPAC

–

–

–

–

HVA

89.08 ± 13.54

72.94 ± 5.48

84.22 ± 13.44

77.47 ± 6.31

74.12 ± 4.94

87.81 ± 13.89

0.5780

0.8945

0.2210

NE

71.61 ± 20.01

96.76 ± 20.59

62.13 ± 12.64

105.61 ± 24.28

86.87 ± 18.17

82.21 ± 23.09

0.4623

0.2330

0.5761

EPI

3.48 ± 0.55

5.92 ± 1.39

4.12 ± 0.88

5.33 ± 1.29

6.51 ± 1.28

2.85 ± 0.59

0.2814

0.4318

0.0293
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Table 2.2 (continued)
The mean  standard error of neurotransmitters found in the cotyledon, hypothalamus and blood plasma in the Fall Study. P-values of
only main effects are shown. (–) represents a significant interaction.
1 A main effect of sex was also observed (P  0.05). Mean ± SE included in Results text.
¶
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Figure 2.1

Neurotransmitter interactions from the Fall Study

Neurotransmitter concentrations from the Fall Study. (A) Nutrition by treatment interaction (P =
0.0084) for serotonin (5-HT) in the hypothalamus. (B) Nutrition by treatment interaction (P =
0.0281) for 3,4-dihydroxy-phenyl acetic acid (DOPAC) in the blood plasma. Data are presented
as mean  standard error. Means with different letters represent significant differences (P <
0.05).
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Table 2.3

Relative gene expression in the Fall Study
Nutrition
ADQ

Treatment
RES

CON

Time

MEL

AM

P-value
PM

Nutrition

Treatment

Time

Cotyledon
COMT

1.60 ± 0.26

2.18 ± 0.31

1.91 ± 0.33

1.89 ± 0.27

2.05 ± 0.33

1.74 ± 0.25

0.1864

0.9914

0.5782

DDC

0.26 ± 0.04

1.34 ± 0.88

1.24 ± 0.94

0.44 ± 0.20

1.23 ± 0.94

0.44 ± 0.20

0.4342

0.4421

0.1228

DRD1

0.93 ± 0.31

0.72 ± 0.25

0.87 ± 0.34

0.77 ± 0.21

0.81 ± 0.25

0.83 ± 0.30

0.5784

0.3043

0.5261

DRD2

1.48 ± 0.64

1.75 ± 0.66

0.46 ± 0.22

2.47 ± 0.70

1.45 ± 0.51

1.79 ± 0.83

0.2534

0.0093

0.6570

YWHAB

1.01 ± 0.11

0.98 ± 0.14

0.92 ± 0.11

1.05 ± 0.14

1.09 ± 0.15

0.89 ± 0.08

0.4126

0.2144

0.1261

MAOA

0.92 ± 0.17

0.76 ± 0.13

0.74 ± 0.18

0.93 ± 0.12

0.98 ± 0.18

0.69 ± 0.09

0.2754

0.0206

0.3359

HTR1A1

0.77 ± 0.26

0.53 ± 0.16

0.72 ± 0.24

0.58 ± 0.19

0.76 ± 0.22

0.54 ± 0.21

0.6608

0.8251

0.9382

SLC6A4

1.26 ± 0.22

1.69 ± 0.34

1.81 ± 0.38

1.17 ± 0.16

1.71 ± 0.34

1.23 ± 0.22

0.1544

0.0879

0.2027

TH

n.d.

n.d.

n.d.

n.d.

n.d.

n.d.

Hypothalamus
COMT

1.18 ± 0.15

1.76 ± 0.55

1.37 ± 0.18

1.59 ± 0.55

1.79 ± 0.54

1.15 ± 0.18

0.3443

0.6389

0.8324

TH

1.41 ± 0.35

2.42 ± 0.44

1.96 ± 0.45

1.87 ± 0.40

1.91 ± 0.42

1.92 ± 0.42

0.1160

0.7365

0.8561

DDC

0.94 ± 0.14

1.52 ± 0.27

1.32 ± 0.20

1.17 ± 0.25

1.16 ± 0.13

1.33 ± 0.31

0.0480

0.1742

0.7574

DRD1

0.69 ± 0.16

2.54 ± 1.62

0.90 ± 0.26

2.35 ± 1.62

0.93 ± 0.25

2.42 ± 1.74

0.1548

0.6438

0.9887

DRD2

0.44 ± 0.04

0.73 ± 0.24

0.47 ± 0.05

0.71 ± 0.25

0.55 ± 0.10

0.64 ± 0.24

0.3701

0.8290

0.5617

YWHAB

0.87 ± 0.07

1.25 ± 0.21

0.95 ± 0.08

0.95 ± 0.08

1.12 ± 0.14

1.02 ± 0.20

0.0780

0.6736

0.8620

MAOA

0.83 ± 0.07

1.25 ± 0.26

0.90 ± 0.09

0.90 ± 0.09

1.07 ± 0.17

1.01 ± 0.24

0.1143

0.9346

0.6216

HTR1A

0.40 ± 0.09

1.36 ± 0.58

0.61 ± 0.15

0.61 ± 0.15

0.77 ± 0.21

1.00 ± 0.58

0.0389

0.7504

0.9432

0.59 ± 0.18

0.59 ± 0.18

–

0.3729

–

SLC6A4

–

–

–

–

The mean  standard error of relative gene expression in the cotyledon and hypothalamus in the Fall Study replicate of the experiment.
P-values of only main effects are shown. (–) represents a significant interaction. (n.d.) represents a gene not detected in the tissue.
1 A main effect of sex was also observed (P  0.05). Mean ± SE included in Results text.
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Figure 2.2

Gene expression interaction from Fall Study

Time by nutrition interaction (P = 0.0433) for solute carrier family 6 member 4 (SLC6A4)
mRNA in the hypothalamus of the Fall Study. Data are presented as mean  standard error.
Means with different letters represent significant differences (P < 0.05).
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Table 2.4

Neurotransmitter concentrations in the Summer Study
Nutrition

Treatment

Time

P-value

ADQ

RES

CON

MEL

AM

PM

Nutrition Treatment

Time

16.25 ± 2.42

12.49 ± 1.95

14.22 ± 2.37

14.36 ± 2.14

17.25 ± 2.31

11.56 ± 1.87

0.3359

0.9832

0.3019

5-HIAA

3.71 ± 0.97

2.61 ± 0.42

2.85 ± 0.33

3.41 ± 0.96

3.01 ± 0.43

3.26 ± 0.93

0.3319

0.5455

0.6005

DA

3.93 ± 0.79

3.45 ± 0.78

2.59 ± 0.48

4.68 ± 0.88

3.56 ± 0.57

3.79 ± 0.93

0.5244

0.1618

0.5814

DOPAC

0.50 ± 0.15

0.25 ± 0.07

0.33 ± 0.12

0.41 ± 0.11

0.24 ± 0.08

0.49 ± 0.14

0.1332

0.4029

0.4996

HVA

1.08 ± 0.19

0.90 ± 0.12

0.81 ± 0.12

1.15 ± 0.17

1.04 ± 0.16

0.94 ± 0.16

0.3807

0.2579

0.5255

NE

0.85 ± 0.47

0.58 ± 0.22

1.08 ± 0.49

0.37 ± 0.13

1.03 ± 0.50

0.41 ± 0.12

0.4399

0.0923

0.2776

–

–

–

–

–

–

7.93 ± 0.55

7.63 ± 0.42

7.02 ± 0.36

0.8988

0.0533

0.3567

–

–

–

–

–

–

2.38 ± 1.15

1.21 ± 0.12

1.13 ± 0.15

2.35 ± 1.06

2.29 ± 1.16

1.29 ± 0.13

0.8938

0.5573

0.6647

HVA

14.28 ± 4.34

10.50 ± 0.76

10.31 ± 0.97

14.16 ± 3.96

13.58 ± 4.39

11.13 ± 0.72

0.6005

0.9223

0.0969

NE

28.87 ± 5.65

48.43 ± 5.28

41.12 ± 5.54

37.12 ± 6.61

31.67 ± 5.92

45.84 ± 5.71

0.0192

0.4646

0.0880

91.92 ± 37.86

102.18 ± 40.71

393.66 ± 247.24

458.58 ± 265.05

64.67 ± 16.70

0.1066

0.4405

0.0216

654.19 ± 117.17

–

–

–

–

0.9017

–

–

Cotyledon
5-HT

Hypothalamus
5-HT
5-HIAA
DA
DOPAC

–

–

8.47 ± 0.50
–

7.75 ± 0.56
–

–
7.80 ± 0.42
–

Plasma
5-HT

429.06 ± 266.17

5-HIAA

685.71 ± 94.81

DA

0.72 ± 0.17

0.28 ± 0.07

0.37 ± 0.08

0.61 ± 0.17

0.50 ± 0.17

0.49 ± 0.11

0.0035

0.1730

0.7896

DOPAC

6.40 ± 2.25

3.50 ± 0.56

4.19 ± 0.40

5.54 ± 2.17

3.33 ± 0.64

6.34 ± 2.05

0.1153

0.6433

0.1368

HVA

98.74 ± 34.23

59.66 ± 9.91

66.32 ± 6.68

89.58 ± 33.03

56.11 ± 12.01

99.01 ± 30.90

0.2521

0.4805

0.2027

NE

80.11 ± 22.38

51.56 ± 23.28

81.80 ± 27.76

50.00 ± 17.50

58.01 ± 26.44

71.96 ± 19.99

0.4256

0.4700

0.5603

EPI

1.88 ± 0.52

1.53 ± 0.45

2.28 ± 0.57

1.16 ± 0.33

1.50 ± 0.53

1.88 ± 0.43

0.4684

0.0395

0.2900

The mean  standard error of neurotransmitters found in the cotyledon, hypothalamus and blood plasma in the Summer Study replicate of the
experiment. P-values of only main effects are shown. (–) represents a significant interaction.
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Figure 2.3

Neurotransmitter interactions in the Summer Study hypothalamus

Neurotransmitter concentrations in the hypothalamus from the Summer Study. (A) Nutrition by
treatment interaction (P = 0.0328) and (B) time by nutrition interaction (P = 0.0092) was
observed for serotonin (5-HT). (C) Nutrition by treatment interaction (P = 0.0410) and (D) and
time by treatment interaction (P = 0.0147) for dopamine (DA). Data are presented as mean 
standard error. Means with different letters represent significant differences (P < 0.05).
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Figure 2.4

Neurotransmitter interaction in the Summer Study blood plasma

Time by treatment interaction (P = 0.0182) for 5-hydroxyindolacetic acid (5-HIAA) in the blood
plasma of the Summer Study. Data are presented as mean  standard error. Means with different
letters represent significant differences (P < 0.05).
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Table 2.5

Relative gene expression in the Summer Study
Nutrition

Treatment

Time

P-value

ADQ

RES

CON

MEL

AM

PM

Nutrition

Treatment

Time

1.21 ± 0.25

0.74 ± 0.11

0.76 ± 0.08

1.16 ± 0.25

1.05 ± 0.27

0.89 ± 0.10

0.0269

0.1122

0.9066

DDC

10.48 ± 2.32

8.58 ± 2.01

10.19 ± 2.24

8.87 ± 2.13

11.17 ± 2.61

8.15 ± 1.72

0.5573

0.7130

0.5263

DRD1

2.08 ± 0.71

0.65 ± 0.11

0.81 ± 0.27

1.83 ± 0.65

1.88 ± 0.71

0.84 ± 0.24

0.0383

0.0186

0.1093

DRD2

7.21 ± 3.17

4.23 ± 1.79

4.64 ± 1.74

6.84 ± 3.22

8.84 ± 3.99

3.50 ± 1.07

0.0235

0.9915

0.4373

YWHAB

0.57 ± 0.07

0.53 ± 0.13

0.60 ± 0.13

0.50 ± 0.07

0.63 ± 0.15

0.48 ± 0.04

0.1970

0.5591

0.4293

MAOA

0.67 ± 0.14

0.41 ± 0.08

0.52 ± 0.10

0.54 ± 0.13

0.64 ± 0.16

0.43 ± 0.06

0.1083

0.7366

0.7647

HTR1A

2.39 ± 0.93

0.84 ± 0.26

1.13 ± 0.37

2.09 ± 0.92

2.46 ± 0.92

0.76 ± 0.23

0.3317

0.1762

0.1805

SLC6A4

1.09 ± 0.38

1.09 ± 0.29

1.20 ± 0.41

0.98 ± 0.26

1.28 ± 0.43

0.91 ± 0.23

0.6666

0.6937

0.8362

n.d.

n.d.

n.d.

n.d.

n.d.

n.d.

COMT

1.03 ± 0.15

0.67 ± 0.07

0.82 ± 0.11

0.87 ± 0.13

0.85 ± 0.11

0.83 ± 0.13

0.0739

0.7967

0.9387

TH

1.06 ± 0.36

0.93 ± 0.26

1.40 ± 0.39

0.63 ± 0.13

1.28 ± 0.39

0.73 ± 0.20

0.2776

0.0228

0.0589

DDC

–

–

–

–

0.69 ± 0.15

0.85 ± 0.11

–

–

0.0061

DRD11

–

–

0.26 ± 0.05

0.49 ± 0.14

–

–

–

0.0992

–

DRD2

0.38 ± 0.11

0.41 ± 0.12

0.45 ± 0.15

0.35 ± 0.07

0.35 ± 0.11

0.44 ± 0.12

0.6872

0.8611

0.2041

YWHAB

0.57 ± 0.07

0.61 ± 0.09

0.55 ± 0.07

0.63 ± 0.09

0.48 ± 0.06

0.70 ± 0.09

0.7992

0.5915

0.0949

MAOA

0.50 ± 0.07

0.55 ± 0.11

0.47 ± 0.07

0.57 ± 0.11

0.37 ± 0.03

0.67 ± 0.11

0.7353

0.5584

0.0100

HTR1A1

0.42 ± 0.15

0.35 ± 0.09

0.25 ± 0.04

0.51 ± 0.15

0.38 ± 0.08

0.39 ± 0.15

0.3705

0.4101

0.4102

SLC6A4

0.52 ± 0.14

0.71 ± 0.21

0.65 ± 0.21

0.58 ± 0.16

0.50 ± 0.13

0.74 ± 0.22

0.7790

0.8995

0.7821

Cotyledon
COMT

TH
Hypothalamus

The mean  standard error of relative gene expression in the cotyledon and hypothalamus in the Summer Study replicate of the experiment. Pvalues of only main effects are shown. (–) represents a significant interaction. (n.d.) represents a gene not detected in the tissue.
1 A main effect of sex was also observed (P  0.05). Mean ± SE included in Results text.
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Figure 2.5

Gene expression interactions in the Summer Study

Gene expression in the hypothalamus from the Summer Study. (A) Nutrition by treatment
interaction (P = 0.0048) for dihydroxyphenylalanine decarboxylase (DDC). (B) Time by
nutrition interaction (P = 0.0071) for dopamine receptor D1 (DRD1). Data are presented as mean
 standard error. Means with different letters represent significant differences (P < 0.05).
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Table 2.6

Spearman correlation coefficients (r) of neurotransmitters across the cotyledon,
blood plasma, and hypothalamus tissues
5-HT

5-HIAA

DA

DOPAC

HVA

NE

EPI

0.4449
(0.0008)
0.5736
(<.0001)
0.2081
(0.1311)
0.3449

0.2627
(0.0550)
0.4034
(0.0025)
0.1659
(0.2306)
0.2561

0.2481
(0.0705)
0.4334
(0.0011)
0.0511
(0.7138)
0.1603

0.1867
(0.1765)
0.3033
(0.0258)
0.0581
(0.6765)
0.0572

0.0488
(0.7259)
0.2348
(0.0874)
0.0063
(0.9638)
0.2780

0.2839
(0.0375)
0.5858
(<.0001)
0.2888
(0.0342)
0.2951

(0.0107)
0.3066
(0.0241)
-0.0386
(0.7817)

(0.0616)
0.2370
(0.0845)
0.1916
(0.1652)

(0.2470)
0.2447
(0.0746)
0.2670
(0.0510)

(0.6814)
0.2455
(0.0241)
0.2294
(0.0952)

(0.0418)
0.0540
(0.6982)
0.1067
(0.4424)

(0.0303)
0.4206
(0.0015)
0.1514
(0.2746)

-0.1086
(0.4344)
0.5172
(<.0001)

0.0088
(0.9494)
0.2215
(0.1074)

-0.0541
(0.6979)
0.1609
(0.2450)

-0.0783
(0.5736)
0.1506
(0.2769)

-0.0606
(0.6635)
0.1691
(0.2216)

-0.0191
(0.8910)
0.3977
(0.0029)

-0.0005
(0.9969)
0.1244
(0.3703)
0.1436
(0.3001)
-0.2032
(0.1406)

-0.0062
(0.9646)
0.0770
(0.5799)
0.1439
(0.2994)
-0.1132
(0.4150)

-0.0520
(0.7089)
0.0337
(0.8090)
0.1962
(0.1551)
-0.1090
(0.4326)

-0.0201
(0.8852)
0.1344
(0.3327)
0.2787
(0.0413)
0.0230
(0.8692)

-0.0717
(0.6067)
-0.1098
(0.4293)
0.0088
(0.9494)
-0.1094
(0.4312)

0.0412
(0.7767)
0.0378
(0.7859)
0.1698
(0.2197)
-0.1112
(0.4234)

0.5323

0.0746

0.0079

0.2861

-0.3619

5-HIAA

(0.7938)
0.0189

(<.0001)
0.6273

(0.5919)
0.0663

(0.9546)
0.1013

(0.0360)
0.3294

(0.0072)
-0.3429

DA

(0.8923)
0.0144

(<.0001)
0.3841

(0.6339)
-0.0347

(0.4659)
0.2567

(0.0150)
0.0565

(0.0111)
-0.1330

(0.9176)

(0.0041)

(0.8033)

(0.0610)

(0.6849)

(0.3378)

Cotyledon vs. Plasma
5-HT
0.3713
(0.0057)
5-HIAA
0.4701
(0.0003)
DA
0.4676
(0.0004)
DOPAC
0.0903
(0.5161)
HVA
0.3948
(0.0031)
NE
0.2880
(0.0347)
Hypothalamus vs. Plasma
5-HT
0.0427
(0.7590)
5-HIAA
0.2537
(0.0642)
DA

-0.1455
(0.2939)
DOPAC
0.1732
(0.2104)
HVA
0.0028
(0.9837)
NE
-0.1547
(0.2640)
Cotyledon vs. Hypothalamus
5-HT
0.0364
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Table 2.6 (continued)
DOPAC
HVA
NE

-0.0337
(0.8089)
0.0915
(0.5106)
0.1563
(0.2590)

0.2439
(0.0755)
0.6583
(<.0001)
0.0860
(0.5363)

-0.0341
0.2177
(0.8068) (0.1138)
0.0926
0.2472
(0.5055) (0.0715)
-0.0701 -0.2159
(0.6144) (0.1169)

-0.0256
(0.8540)
0.4241
(0.0014)
0.1674
(0.2262)

-0.2066
(0.1339)
-0.2691
(0.0491)
0.0241
(0.8627)

Spearman correlation coefficients (r) for serotonin (5-HT), hydroxyindolacetic acid (5-HIAA),
dopamine (DA), 3,4-dihydroxy-phenyl acetic acid (DOPAC), homovanillic acid (HVA),
norepinephrine (NE), and epinephrine (EPI) across the cotyledon, blood plasma, and
hypothalamus tissues. P-values are presented in parenthesis.
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Table 2.7

Spearman correlation coefficients (r) between neurotransmitters and the genes of
interest in the hypothalamus

5-HT
5-HIAA
DA
DOPAC
HVA
NE
COMT
-0.1351
0.0244
-0.0756
-0.0141
0.1444
0.0453
(0.3300)
(0.8608)
(0.5868)
(0.9194)
(0.2977)
(0.7451)
TH
0.1173
0.0117
0.1785
0.1846
0.1731
0.0405
(0.4076)
(0.9344)
(0.2056)
(0.1901)
(0.2196)
(0.7758)
DDC
0.1837
0.0292
0.1407
-0.0242
0.0460
0.1418
(0.1837)
(0.8340)
(0.3101)
(0.8621)
(0.7413)
(0.3065)
DRD1
0.1290
0.4693
0.2036
0.2019
0.3276
-0.2561
(0.3524)
(0.0003)
(0.1398)
(0.1432)
(0.0156)
(0.0616)
DRD2
-0.0155
0.2124
0.1354
0.1508
0.3843
0.1016
(0.9113)
(0.1230)
(0.3288)
(0.2763)
(0.0041)
(0.4647)
YWHAB
0.1027
0.3226
0.1998
0.0532
0.2694
0.1242
(0.4598)
(0.0174)
(0.1475)
(0.7027)
(0.0489)
(0.3711)
MAOA
0.1097
0.3540
0.1815
-0.0280
0.2701
0.0298
(0.4296)
(0.0086)
(0.1891)
(0.8410)
(0.0483)
(0.8308)
HTR1A
0.1315
0.3008
0.0296
0.0140
0.2709
-0.0927
(0.3479)
(0.0286)
(0.8332)
(0.9206)
(0.0498)
(0.5094)
SLC6A4
-0.0718
0.0669
-0.2100
-0.1283
-0.0285
-0.1477
(0.6132)
(0.6373)
(0.1351)
(0.3647)
(0.8409)
(0.2962)
Spearman correlation coefficients (r) between the neurotransmitters, serotonin (5-HT),
hydroxyindolacetic acid (5-HIAA), dopamine (DA), 3,4-dihydroxy-phenyl acetic acid (DOPAC),
homovanillic acid (HVA), norepinephrine (NE), and the genes of interest, catechol-Omethyltransferase (COMT), tyrosine hydroxylase (TH), dihydroxyphenylalanine decarboxylase
(DDC), dopamine receptor D1 (DRD1), dopamine receptor D2 (DRD2), 5-hydroxytryptamine
receptor 1A (HTR1A), solute carrier family 6 member 4 (SLC6A4), monoamine oxidase A
(MAOA), and tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta
(YWHAB) in the hypothalamus. P-values are presented in parenthesis.
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Table 2.8

Spearman correlation coefficients (r) between neurotransmitters and the genes of
interest in the cotyledon

5-HT
5-HIAA
DA
DOPAC
HVA
NE
COMT
0.0720
0.3348
0.1219
0.1054
0.2468
0.0749
(0.6049)
(0.0133)
(0.3799)
(0.4480)
(0.0720)
(0.5905)
DDC
-0.3455
-0.5344
-0.0078
-0.1008
-0.4113
0.2416
(0.0130)
(<.0001)
(0.9565)
(0.4816)
(0.0027)
(0.0877)
DRD1
-0.1594
-0.1438
0.1316
0.1514
-0.0220
-0.1409
(0.2497)
(0.2995)
(0.3428)
(0.2745)
(0.8748)
(0.3094)
DRD2
-0.1269
-0.1635
0.0250
0.1683
-0.2550
-0.0641
(0.4116)
(0.2890)
(0.8719)
(0.2748)
(0.0948)
(0.6795)
YWHAB
0.2354
0.4533
0.1722
0.1183
0.3941
0.2687
(0.0867)
(0.0006)
(0.2131)
(0.3944)
(0.0032)
(0.0495)
MAOA
0.0229
0.2150
0.1737
0.2552
0.1998
-0.0254
(0.8707)
(0.1222)
(0.2136)
(0.0651)
(0.1515)
(0.8568)
HTR1A
-0.0259
-0.1197
0.0032
-0.0111
-0.0785
0.0487
(0.8556)
(0.3980)
(0.9823)
(0.9379)
(0.5801)
(0.7318)
SLC6A4
0.2563
0.3293
-0.0075
-0.0725
0.2698
0.3170
(0.0614)
(0.0150)
(0.9570)
(0.6025)
(0.0485)
(0.0195)
Spearman correlation coefficients (r) between the neurotransmitters, serotonin (5-HT),
hydroxyindolacetic acid (5-HIAA), dopamine (DA), 3,4-dihydroxy-phenyl acetic acid (DOPAC),
homovanillic acid (HVA), norepinephrine (NE), and the genes of interest, catechol-Omethyltransferase (COMT), tyrosine hydroxylase (TH), dihydroxyphenylalanine decarboxylase
(DDC), dopamine receptor D1 (DRD1), dopamine receptor D2 (DRD2), 5-hydroxytryptamine
receptor 1A (HTR1A), solute carrier family 6 member 4 (SLC6A4), monoamine oxidase A
(MAOA), and tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta
(YWHAB) in the cotyledon. P-values are presented in parenthesis.
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Table 2.9

Spearman correlation coefficients (r) between fetal body weight and
neurotransmitter concentrations by tissue
Fetal Body Weight
vs. Cotyledon
-0.0136
(0.9224)
0.0621
(0.6556)
0.1378
(0.3205)
0.0804
(0.5634)
0.0674
(0.6282)
0.0702
(0.6142)

Fetal Body Weight
vs. Hypothalamus
-0.0337
(0.8091)
0.0266
(0.8485)
-0.0491
(0.7244)
-0.1578
(0.2545)
0.0445
(0.7496)
0.0747
(0.5913)

Fetal Body Weight
vs. Blood Plasma
5-HT
-0.0055
(0.9688)
5-HIAA
-0.0887
(0.5234)
DA
-0.1164
(0.4020)
DOPAC
-0.1257
(0.3650)
HVA
-0.1859
(0.1783)
NE
-0.0845
(0.5436)
EPI
-0.0049
(0.9718)
Spearman correlation coefficients (r) between the neurotransmitters, serotonin (5-HT),
hydroxyindolacetic acid (5-HIAA), dopamine (DA), 3,4-dihydroxy-phenyl acetic acid (DOPAC),
homovanillic acid (HVA), norepinephrine (NE), and epinephrine (EPI) in the cotyledon,
hypothalamus, and blood plasma, and fetal body weights previously reported in ContrerasCorrea et al. (2021). P-values are presented in parenthesis.
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Figure 2.6

Diagram of study results

Seasonal differences in neurotransmitter pathways were observed in this study. (A) Previously,
Contreras-Correa et al. (2021) reported nutrient restriction decreased fetal body weight with no
rescue effect from melatonin supplementation in the fall. Additionally, plasma serotonin (5-HT)
was increased in response to nutrient restriction (RES) and melatonin supplementation (MEL).
Plasma epinephrine (EPI) concentration decreased from 0500h (AM) to 1300h (PM). In the
cotyledon, tyrosine hydroxylase (TH) was not detected and melatonin supplementation increased
5-hydroxyindolacetic acid (5-HIAA), dopamine (DA), 3,4-dihydroxy-phenyl acetic acid
(DOPAC), homovanillic acid (HVA), and monoamine oxidase A (MAOA) transcript abundance,
indicating overall increases in neurotransmitter metabolism. (B) Previously, Contreras-Correa et
al. (2021) reported melatonin supplementation rescued fetal body weights in the summer. Plasma
DA decreased in response to RES and EPI decreased in response to MEL. Plasma 5-HT
decreased from AM to PM. In the cotyledon, only DRD1 and DRD2 were downregulated in
response to RES. Additionally, in the hypothalamus, DA and dihydroxyphenylalanine
decarboxylase (DDC) displayed a similar nutrition by treatment interaction where concentrations
were increased in the RES-MEL group compared to the ADQ-MEL group.
1 From results by Contreras-Correa et al. (2021)
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CHAPTER III
GENERAL DISCUSSION
Neurotransmitters have long been recognized for the roles they play in regulating
cognition, emotion and behavior (Carrasco and Van de Kar, 2003). More recently, it has come to
light that neurotransmitters may be one of the mechanisms responsible for programming effects
in utero. Serotonin specifically has become a hot topic in developmental programming of the
brain as there is accumulating evidence supporting serotonin as a contributor to mental illness in
humans (Hendricks et al., 2003; Yang et al., 2014). Dopamine metabolism and signaling has also
been implicated in mental illness within disorders like schizophrenia and attention deficit
hyperactivity disorder (ADHD) (Heinz and Schlagenhauf, 2010; Tripp and Wickens, 2012).
Bonnin and Levitt (2011) proposed that the placenta is the primary source of fetal serotonin as it
synthesizes the neurotransmitter. Catecholamines have also been proposed to be synthesized by
the placenta (Zhu et al., 2002; Mao et al., 2020). These results have led to increased interest in
the role of neurotransmitters in fetal programming, with most recently a review by Rosenfeld
(2021) coining the term placenta-brain-axis.
The greatest amount of research into neurotransmitters has been done in association with
FGR in humans and IUGR in animal models. Maternal undernutrition can result in decreased
fetal weights and increased risk for metabolic disease in later life in animal and human models
(Long et al., 2009; Zhu et al., 2006; Stein et al., 2004). It is an estimated that FGR occurs in 510% of all human pregnancies worldwide (Frøen et al., 2004). Additionally, in humans,
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increased serotonin has been reported in response to FGR (Ranzil et al., 2019a). Recently,
studies of IUGR in litter-bearing species such as rabbits and pigs have shown changes in
neurotransmitter profiles in response to nutrient restriction with some conflicting results in HVA
and DOPAC concentrations (Garcia-Contreras et al., 2017; Vasquez-Gomez et al., 2016;
Hernandez-Andrade et al., 2015).
Melatonin supplementation has emerged as a therapeutic to rescue effects of nutrient
restriction. Most commonly, it is associated with the roles it plays in modulating circadian
rhythms (Arendt, 1998) However, melatonin is also able to cross the placenta unaltered and
functions as both an antioxidant and modulator of blood flow (Tamura et al., 2008; Paulis and
Simko, 2007; Lemley et al., 2013). Previous research has shown increased umbilical blood flow
in sheep and increased uterine artery blood flow in cattle (Lemley et al., 2012; Brockus et al.,
2016). Most recently, our lab found that melatonin supplementation increased uterine blood flow
in late gestation of Brangus heifers (Contreras-Correa et al., 2021). Additionally, ContrerasCorrea et al. (2021) found fetal weights were rescued by melatonin supplementation in nutrient
restricted dams in a seasonally dependent manner, likely due to the role of melatonin as a
circadian rhythm modulator and changes in photoperiod with season. Using the same fetuses
from Contreras-Correa et al. (2021), this project aimed to determine the effects of maternal
nutrient restriction, melatonin supplementation, and time of sampling on the presence of
neurotransmitters and relative gene expression in the fetal hypothalamus, blood and cotyledon.
Similarly to Contreras-Correa et al., drastic seasonal differences were observed. Most
notably, in the fall study, plasma serotonin was increased by 12.5-fold in the nutrient restricted
animals. Additionally, plasma serotonin was increased by 2-fold in the melatonin supplemented
group. With this, HTR1A, the serotonin receptor, was increased 3.5-fold in the nutrient restricted
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group in the hypothalamus. Given the negative implications of hyperserotonemia, these results
raise questions about what negative consequences may arise in later-life. In the fall cotyledon
samples, melatonin supplementation increased 5-HIAA, DA, DOPAC, HVA and MAOA.
Overall, this indicated an increase in metabolism of serotonin and dopamine.
In the summer replicate, Contreras-Correa et al. (2021) observed a rescue effect of
melatonin on fetal body weights. Though serotonin showed temporal changes in the plasma,
there were more results associated with catecholamine pathways. Plasma dopamine was
decreased 2.5-fold in the nutrient restricted animals and epinephrine was decreased 2-fold in the
melatonin supplemented plasma. In the cotyledon, no differences were observed in concentration
of neurotransmitters, but nutrient restricted groups had decreased DRD1 and DRD2 transcript
abundance. Additionally, within the hypothalamus, dopamine and the enzyme directly
synthesizing dopamine, DDC, had a similar nutrition by treatment effect where the RES-MEL
group had increased dopamine and DDC compared to the ADQ-MEL group.
Overall, these results indicate an intimate relationship between nutrient restriction and
changes in neurotransmitter pathways. Melatonin supplementation in the fall increased serotonin
and its metabolism, and the metabolism of dopamine. In the summer, catecholamine pathways
were affected more than the serotonin pathway. Decreases in dopamine in the blood and
dopamine receptors in the cotyledon suggest that systemic dopamine may be decreased in
response to nutrient restriction. In concert with melatonin rescuing fetal body weights in the
study by Contreras-Correa et al. (2021), melatonin did not affect neurotransmitters in the
placenta. Generally, this points to a closer relationship to FGR and neurotransmitters than
melatonin, but in the case of rescue effects, melatonin may inadvertently regulate
neurotransmitters in the placenta.
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Genes such as MAOA and COMT have been associated with aggression, with MAOA
polymorphisms being directly implicated in aggression in cattle (Eusebi et al., 2020; Gogos et
al., 1998). The hyperserotonemia seen here would be greatly concerning in humans due to the
association with ASD (Ranzil et al., 2019a; Ranzil et al., 2019b). However, there truly is no
behavioral analogue to ASD in cattle. Dopamine and in utero nutrition have been implicated in
altering food preferences in humans, but may alter feeding behavior as well (Van der Laan et al.,
2016). However, in general the implications of these results in cattle is largely unknown.
Currently, few research articles report results including full neurotransmitter profiles
outside of the traditional mouse and human models, with no studies on neurotransmitter profiles
conducted in cattle. Literature reporting neurotransmitter profiles in response to nutrient
restriction in utero is also minimal, with no studies looking at production of neurotransmitters as
a programming mechanism in cattle, or other livestock species. This research represents the first
of its kind with documentation of neurotransmitters in the fetal bovine and placenta and
relationships between neurotransmitters and their pathways providing plausible mechanisms of
programming effects in cattle via the placenta. However, one major limitation of this study is
that the sampling occurred only at one time-point in late-gestation. With neural and
developmental plasticity so high earlier in pregnancy, it would be beneficial to also document
neurotransmitter profiles over the course of pregnancy and into post-natal life. Additional
research is needed to better understand the effects of other insults during pregnancy on fetal
neurotransmitters. Additionally, documentation neurotransmitters in cattle in later life may be a
future research direction. With potential impacts on aggression and feeding behaviors, future
studies should look at animal behavior as a response to changes in neurotransmitters in utero.
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